{"content":"<li class=\"n-box-item date-title\" data-end=\"1571371199\" data-start=\"1571284800\" data-txt=\"Monday, December 23, 2019\">Thursday, October 17, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3506769\" data-ts=\"1571351258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALKS\" target=\"_blank\">ALKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506769-alkermesplus-1_5-on-tentative-vumerity-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alkermes +1.5% on tentative Vumerity approval</a></h4><ul>   <li>Alkermes (NASDAQ:<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a>) is <font color=\"green\">up 1.5%</font> after <a href=\"https://seekingalpha.com/filing/4667071\" target=\"_blank\">disclosing it's gotten a tentative FDA approval</a> for Vumerity (diroximel fumarate) for treating relapsing forms of multiple sclerosis.</li>    <li>Final approval is subject to the \"expiration of a period of patent protection and/or exclusivity.\"</li>    <li>The company says it believes this period relates to the term of a patent of the reference listed drug product that's set to expire Oct. 20.</li>    <li>It filed its new drug application in December 2018, and certified to applicable patents of the reference listed drug product assuming a PDUFA action date in December 2019, aiming for a commercial launch as soon as possible after that.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506769\" data-linked=\"Alkermes +1.5% on tentative Vumerity approval\" data-tweet=\"$ALKS - Alkermes +1.5% on tentative Vumerity approval https://seekingalpha.com/news/3506769-alkermesplus-1_5-on-tentative-vumerity-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3506769-alkermesplus-1_5-on-tentative-vumerity-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506763\" data-ts=\"1571349476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIL\" target=\"_blank\">GIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506763-gildanminus-12_5-on-preliminary-results-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gildan -12.5% on preliminary results, guidance cut</a></h4><ul>   <li>Gildan Activewear (NYSE:<a href='https://seekingalpha.com/symbol/GIL' title='Gildan Activewear Inc.'>GIL</a>) is <font color=\"red\">12.5% lower</font> postmarket after posting <a href=\"https://seekingalpha.com/pr/17666933-gildan-activewear-announces-preliminary-third-quarter-2019-results-updates-2019-full-year\" target=\"_blank\">preliminary results</a> that fell short of guidance and cutting its profit forecast.</li>    <li>It's expecting to report GAAP diluted EPS for Q3 of $0.51 and adjusted diluted EPS of $0.53, both down 7% Y/Y vs. previous guidance for a flat result.</li>    <li>Sales are expected at $740M, down 2% (vs. projections for mid-single-digit growth): $620M in activewear and $120M in hosiery/underwear.</li>    <li>\"During the third quarter of 2019, we experienced significantly weaker than expected demand for imprintables in North America and ongoing softness in international imprintable markets,\" the company says.</li>    <li>The company's revising forecasts lower as it assumes the imprintables weakness worldwide will persist in Q4. It's cutting Q4 sales estimates by $70M on lower demand expectations, and sees distributor inventory destocking negatively impacting sales by $100M.</li>    <li>It now expects full-year sales to be down low single digits vs. 2018. Adjusted diluted EPS is forecast at $1.65-$1.70.</li>    <li>The company will report Q3 results on Oct. 31 before the open.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506763\" data-linked=\"Gildan -12.5% on preliminary results, guidance cut\" data-tweet=\"$GIL - Gildan -12.5% on preliminary results, guidance cut https://seekingalpha.com/news/3506763-gildanminus-12_5-on-preliminary-results-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3506763-gildanminus-12_5-on-preliminary-results-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506760\" data-ts=\"1571348948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506760-prtk-clvs-ozk-and-gil-among-notable-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PRTK, CLVS, OZK and GIL among notable after hours movers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a> <font color=\"green\">+5.5%</font>. <a href='https://seekingalpha.com/symbol/KOD' title='Kodiak Sciences Inc.'>KOD</a> <font color=\"green\">+4.9%</font>. <a href='https://seekingalpha.com/symbol/MRTN' title='Marten Transport, Ltd.'>MRTN</a> <font color=\"green\">+3.2% </font><a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a> <font color=\"green\">+2.9%</font>. <a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology, Inc.'>CLVS</a> <font color=\"green\">+2.5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CVTI' title='Covenant Transportation Group, Inc.'>CVTI</a> <font color=\"red\">-13.3%</font>. <a href='https://seekingalpha.com/symbol/GIL' title='Gildan Activewear Inc.'>GIL</a> <font color=\"red\">-12.4%</font>. <a href='https://seekingalpha.com/symbol/EXPO' title='Exponent, Inc.'>EXPO</a> <font color=\"red\">-6%</font>. <a href='https://seekingalpha.com/symbol/WDFC' title='WD-40 Company'>WDFC</a> <font color=\"red\">-5%</font>. <a href='https://seekingalpha.com/symbol/OZK' title='Bank OZK'>OZK</a> <font color=\"red\">-3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506760\" data-linked=\"PRTK, CLVS, OZK and GIL among notable after hours movers\" data-tweet=\"$PRTK $KOD $MRTN - PRTK, CLVS, OZK and GIL among notable after hours movers https://seekingalpha.com/news/3506760-prtk-clvs-ozk-and-gil-among-notable-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506760-prtk-clvs-ozk-and-gil-among-notable-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506762\" data-ts=\"1571348851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTK\" target=\"_blank\">PRTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506762-paratekplus-5_5-on-withdrawing-europe-application-for-nuzyra\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Paratek +5.5% on withdrawing Europe application for Nuzyra</a></h4><ul>    <li>Paratek Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a>) is <font color=\"green\">up 5.5%</font> postmarket after it announced it's <a href=\"https://seekingalpha.com/pr/17666772-paratek-withdraws-european-marketing-authorization-application-oral-intravenous-nuzyra-skin\" target=\"_blank\">withdrawn its application</a> to the European Medicines Agency for marketing authorization for Nuzyra (omadacycline).</li>    <li>The EMA is recommending approval of Nuzyra for treating acute bacterial skin and skin structure infections, but not for community-acquired bacterial pneumonia -- saying a second study is required for that indication.</li>    <li>The company wants an approval of both indications concurrently, since a 10-year market exclusivity would begin with the first approval.</li>    <li>It plans to resubmit the application after completion of a CABP study already agreed to with the FDA.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506762\" data-linked=\"Paratek +5.5% on withdrawing Europe application for Nuzyra\" data-tweet=\"$PRTK - Paratek +5.5% on withdrawing Europe application for Nuzyra https://seekingalpha.com/news/3506762-paratekplus-5_5-on-withdrawing-europe-application-for-nuzyra?source=tweet\" data-url=\"https://seekingalpha.com/news/3506762-paratekplus-5_5-on-withdrawing-europe-application-for-nuzyra\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506759\" data-ts=\"1571348073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506759-tplus-1_3-on-report-of-talks-elliott-over-campaign\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T +1.3% on report of talks with Elliott over campaign</a></h4><ul>   <li>AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) is <font color=\"green\">up 1.3%</font> after hours as the <i>WSJ</i> reports the company's in talks with Elliott Management to <a href=\"https://www.wsj.com/articles/at-t-in-talks-to-resolve-elliott-managements-activist-campaign-11571347183?mod=searchresults&amp;page=1&amp;pos=4\" target=\"_blank\">resolve that firm's activist campaign</a> for changes.</li>    <li>It's a deal that could come this month (or yet fall apart).</li>    <li>A number of items are under discussion, according to the report, including launching a strategic review of assets for disposal, a push to improve margins, a stock buyback or board changes on which Elliott would consult.</li><li>A delay in AT&amp;T's earnings release from next week to Oct. 28 should set up more time for an agreement.</li><li>Elliott has reportedly assembled a list of board candidates, and if the peace deal fails, they could become the seeds of a proxy fight next year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506759\" data-linked=\"AT&amp;T +1.3% on report of talks with Elliott over campaign\" data-tweet=\"$T - AT&amp;T +1.3% on report of talks with Elliott over campaign https://seekingalpha.com/news/3506759-tplus-1_3-on-report-of-talks-elliott-over-campaign?source=tweet\" data-url=\"https://seekingalpha.com/news/3506759-tplus-1_3-on-report-of-talks-elliott-over-campaign\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>126&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506731\" data-ts=\"1571345209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRXC\" target=\"_blank\">TRXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506731-transenterix-to-restructure-shares-down-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransEnterix to restructure; shares down 6% after hours</a></h4><ul><li>TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) has <a href=\"https://seekingalpha.com/pr/17666867-transenterix-provides-corporate-update\" target=\"_blank\">engaged</a> JPMorgan Securities, LLC to advise it on strategic alternatives while it implements a restructuring plan aimed at reducing operating expenses.</li><li>CFO Joseph Slattery will retire at year-end.</li><li>The $17M AutoLap transaction has been amended under which the company will be paid in $3M installments.</li><li>Shares down <font color=\"red\">6%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506731\" data-linked=\"TransEnterix to restructure; shares down 6% after hours\" data-tweet=\"$TRXC - TransEnterix to restructure; shares down 6% after hours https://seekingalpha.com/news/3506731-transenterix-to-restructure-shares-down-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3506731-transenterix-to-restructure-shares-down-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506717\" data-ts=\"1571344269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTRH\" target=\"_blank\">WTRH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506717-rbc-steps-to-waitr-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC steps to Waitr sidelines</a></h4><ul><li>Waitr Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WTRH' title='Waitr Holdings Inc.'>WTRH</a>) is cut from Outperform to Sector Perform at RBC.</li><li>The price target is set at $1, a 62% upside.</li><li>Yesterday, WTRH <a href=\"https://seekingalpha.com/news/3506304-waitr-cfo-board-members-exit\" target=\"_blank\">announced</a> the departures of its CFO and two board members.</li><li>Waitr shares are <font color=\"green\">up 6.9%</font> after hours to $0.66.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506717\" data-linked=\"RBC steps to Waitr sidelines\" data-tweet=\"$WTRH - RBC steps to Waitr sidelines https://seekingalpha.com/news/3506717-rbc-steps-to-waitr-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3506717-rbc-steps-to-waitr-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506710\" data-ts=\"1571343862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506710-intuitive-up-2-after-hours-on-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive up 2% after hours on Q3 beat</a></h4><ul><li>Intuitive Surgical (NASDAQ:<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a>) <a href=\"https://seekingalpha.com/pr/17666771-intuitive-announces-third-quarter-earnings\" target=\"_blank\">Q3 results</a>:</li><li>Revenues: $1,228.2M (+22.5%); Instruments &amp; accessories: $606.2M (+24.7%); Systems: $338.6M (+23.3%); Services: $183.4M (+14.6%).</li><li>Global da Vinci procedures up almost 20%.</li><li>Da Vinci system shipments: 275 (+19%).</li><li>Net income: $396.8M (+35.7%); non-GAAP net income: $408.8M (+21.3%); EPS: $3.33 (+35.9%); non-GAAP EPS: $3.43 (+21.2%).</li><li>Shares up <font color=\"green\">2%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506681-intuitive-surgical-eps-beats-0_44-beats-revenue\" target=\"_blank\">Intuitive Surgical EPS beats by $0.44, beats on revenue</a> (Oct. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506710\" data-linked=\"Intuitive up 2% after hours on Q3 beat\" data-tweet=\"$ISRG - Intuitive up 2% after hours on Q3 beat https://seekingalpha.com/news/3506710-intuitive-up-2-after-hours-on-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3506710-intuitive-up-2-after-hours-on-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506705\" data-ts=\"1571343618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEAM\" target=\"_blank\">TEAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506705-atlassianminus-2_3-after-beats-code-barrel-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlassian -2.3% after beats, Code Barrel acquisition</a></h4><ul><li>Atlassian (NASDAQ:<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian Corporation Plc'>TEAM</a>)<font color=\"red\"> -2.3% </font><a href=\"https://seekingalpha.com/news/3506665-atlassian-eps-beats-0_04-beats-revenue\" target=\"_blank\">reports Q1 beats </a>with 36% Y/Y revenue growth and upside Q2 guidance that sees revenue of $386-390M (consensus: $381.6M), EPS of $0.27 (consensus: $0.26), and 86% gross margin (consensus: 85.8%).</li><li>The FY outlook has revenue of $1.56-1.57B (consensus: $1.55B) and EPS of $1.00, one cent below consensus. Gross margin is forecast at 85-86% (consensus: 85.4%). Capex is expected at $30M for the year.</li><li>Q1 cash flow from operations totaled $76.2M and FCF came in at $62.4M.</li><li>Acquisition: Atlassian buys Code Barrel, which created Automation for Jira, a tool for simplifying routines in Jira without knowing code. Terms weren't disclosed.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.atlassian.com&amp;esheet=52113252&amp;newsitemid=20191017005894&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.atlassian.com&amp;index=3&amp;md5=8241b03db2b140cb27d8ed61f79088f5\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17666713-atlassian-announces-first-quarter-fiscal-year-2020-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506705\" data-linked=\"Atlassian -2.3% after beats, Code Barrel acquisition\" data-tweet=\"$TEAM - Atlassian -2.3% after beats, Code Barrel acquisition https://seekingalpha.com/news/3506705-atlassianminus-2_3-after-beats-code-barrel-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3506705-atlassianminus-2_3-after-beats-code-barrel-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506681\" data-ts=\"1571342824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506681-intuitive-surgical-eps-beats-0_44-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive Surgical EPS beats by $0.44, beats on revenue</a></h4><ul><li>Intuitive Surgical (NASDAQ:<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a>): Q3 Non-GAAP EPS of $3.43 <font color=\"green\">beats by $0.44</font>; GAAP EPS of $3.33 <font color=\"green\">beats by $0.96</font>.</li><li>Revenue of $1.13B (+22.7% Y/Y) <font color=\"green\">beats by $70M</font>.</li><li>Shares <font color=\"green\">+4.06%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17666771-intuitive-announces-third-quarter-earnings\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3506681\" data-linked=\"Intuitive Surgical EPS beats by $0.44, beats on revenue\" data-tweet=\"$ISRG - Intuitive Surgical EPS beats by $0.44, beats on revenue https://seekingalpha.com/news/3506681-intuitive-surgical-eps-beats-0_44-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3506681-intuitive-surgical-eps-beats-0_44-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506677\" data-ts=\"1571342787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETFC\" target=\"_blank\">ETFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506677-e-trade-financial-eps-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E*TRADE Financial EPS beats by $0.02, beats on revenue</a></h4><ul><li>E*TRADE Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>): Q3 Non-GAAP EPS of $1.04 <font color=\"green\">beats by $0.02</font>; GAAP EPS of $1.08 <font color=\"green\">beats by $0.07</font>.</li><li>Revenue of $767M (+6.5% Y/Y) <font color=\"green\">beats by $24.17M</font>.</li><li>Shares <font color=\"green\">+2.9%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17666747-e-trade-financial-corporation-announces-third-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3506677\" data-linked=\"E*TRADE Financial EPS beats by $0.02, beats on revenue\" data-tweet=\"$ETFC - E*TRADE Financial EPS beats by $0.02, beats on revenue https://seekingalpha.com/news/3506677-e-trade-financial-eps-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3506677-e-trade-financial-eps-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506663\" data-ts=\"1571342186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506663-t-closer-to-sale-of-central-european-media-reports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T closer to sale of Central European Media - reports</a></h4><ul>   <li>Investment group PPF is <a href=\"https://www.reuters.com/article/us-central-euro-m-a-ppf-idUSKBN1WW2EU\" target=\"_blank\">closing in on a deal</a> to buy a majority stake in Central European Media (<a href=\"http://seekingalpha.com/symbol/CETV\" target=\"_blank\">CETV</a> <font color=\"green\">+10.1%</font>) from AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>).</li>    <li>AT&amp;T owns 64% of CME's equity but controls 75% of the company via preferred stock, a position inherited from its acquisition of Time Warner.</li>    <li>PPF's Petr Kellner, the richest man in the Czech Republic, is handling talks personally and a deal could be announced within days, according to regional reports.</li>    <li>CME has a market cap of $1.13B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506663\" data-linked=\"AT&amp;T closer to sale of Central European Media - reports\" data-tweet=\"$T $CETV - AT&amp;T closer to sale of Central European Media - reports https://seekingalpha.com/news/3506663-t-closer-to-sale-of-central-european-media-reports?source=tweet\" data-url=\"https://seekingalpha.com/news/3506663-t-closer-to-sale-of-central-european-media-reports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506660\" data-ts=\"1571341349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FQVLF\" target=\"_blank\">FQVLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506660-first-quantumplus-13-jiangxi-copper-backed-firm-raises-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Quantum +13% as Jiangxi Copper-backed firm raises stake</a></h4><ul><li>First Quantum Minerals (<a href='https://seekingalpha.com/symbol/FQVLF' title='First Quantum Minerals Ltd.'>OTCPK:FQVLF</a>) surges as much as 17% after an investment firm backed by China's Jiangxi Copper <a href=\"https://www.reuters.com/article/us-first-quantum-stocks/first-quantum-shares-jump-after-jiangxi-copper-backed-firm-boosts-stake-idUSKBN1WW2J8\" target=\"_blank\">increased its stake in the company</a>.</li><li>Pangaea Investment Management says it purchased 6M additional shares in First Quantum, bringing its stake to 74.64M shares, or 10.8%, and has entered into a forward contract that could allow it to buy another 40M shares.</li><li>First Quantum said <a href=\"https://seekingalpha.com/news/3501087-first-quantum-minerals-swears-takeover-talks\" target=\"_blank\">last month</a> that it was in talks with Jiangxi Copper for a potential sale of a minority interest in its Zambian copper assets.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506660\" data-linked=\"First Quantum +13% as Jiangxi Copper-backed firm raises stake\" data-tweet=\"$FQVLF - First Quantum +13% as Jiangxi Copper-backed firm raises stake https://seekingalpha.com/news/3506660-first-quantumplus-13-jiangxi-copper-backed-firm-raises-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3506660-first-quantumplus-13-jiangxi-copper-backed-firm-raises-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506657\" data-ts=\"1571340846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNH\" target=\"_blank\">UNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506657-health-insurers-add-to-rally-after-unh-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health insurers add to rally after UNH Q3 beat</a></h4><ul><li>UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"green\">+3.2%</font>) adds to its <a href=\"https://seekingalpha.com/news/3505675-unitedhealth-2-percent-premarket-beat-raise\" target=\"_blank\">Q3 results</a>-stoked rally on 15% higher volume. Shares have perked up <font color=\"green\">11%</font> since it reported better-than-expected results two days ago that included a guidance boost. Health insurance peers and managed care providers are enjoying the ride as well.</li><li>Selected tickers: eHealth (<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color=\"green\">+6.3%</font>), Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a> <font color=\"green\">+3.3%</font>), WellCare Health Plans (<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a> <font color=\"green\">+2.2%</font>), Triple-S Management (<a href='https://seekingalpha.com/symbol/GTS' title='Triple-S Management Corporation'>GTS</a> <font color=\"green\">+4.4%</font>), Molina Healthcare (<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <font color=\"green\">+3.1%</font>), Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color=\"green\">+3.7%</font>), Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"green\">+2%</font>), Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color=\"green\">+3.4%</font>), Anthem (<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color=\"green\">+1.9%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506657\" data-linked=\"Health insurers add to rally after UNH Q3 beat\" data-tweet=\"$UNH $EHTH $HIIQ - Health insurers add to rally after UNH Q3 beat https://seekingalpha.com/news/3506657-health-insurers-add-to-rally-after-unh-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3506657-health-insurers-add-to-rally-after-unh-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506656\" data-ts=\"1571339730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPC\" target=\"_blank\">MPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506656-marathon-petroleum-investors-discussing-ceo-board-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marathon Petroleum investors discussing CEO with board - Bloomberg</a></h4><ul><li>Marathon Petroleum (<a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corporation'>MPC</a> <font color='green'>+2.3%</font>) board members are <a href=\"https://finance.yahoo.com/news/marathon-petroleum-board-investors-said-152207289.html\" target=\"_blank\">meeting with activist investors</a> to discuss CEO Gary Heminger's future and the company's strategy, with the aim of making decisions by the time of the company's Q3 earnings call on Oct. 31, Bloomberg reports.</li><li>After investors Paul Foster and Jeff Stevens met with several board members yesterday, representatives for Elliott Management and D.E. Shaw plan meetings with directors today, according to the report.</li><li>The activists are said to view Executive Vice Chairman Greg Goff, who joined MPC after its purchase of Andeavor, as a potential replacement for Heminger.</li><li>\"Marathon has delivered substantial shareholder value under the leadership of Chairman and CEO Gary Heminger, who has the full support of the board,\" MPC says in a statement, adding that it is \"conducting a comprehensive strategic review, and has been collecting feedback from many shareholders.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3506656\" data-linked=\"Marathon Petroleum investors discussing CEO with board - Bloomberg\" data-tweet=\"$MPC - Marathon Petroleum investors discussing CEO with board - Bloomberg https://seekingalpha.com/news/3506656-marathon-petroleum-investors-discussing-ceo-board-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3506656-marathon-petroleum-investors-discussing-ceo-board-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506655\" data-ts=\"1571339586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDC\" target=\"_blank\">SDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506655-smiledirect-drops-after-short-seller-tweets-raids-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SmileDirect drops after short-seller tweets about &#39;raids&#39; (updated)</a></h4><ul><li>SmileDirect Club (NASDAQ:<a href='https://seekingalpha.com/symbol/SDC' title='SmileDirectClub, Inc.'>SDC</a>), now <font color=\"red\">down 5.2%</font>, fell as much as 13% after short-seller Hindenberg Researc<a href=\"https://twitter.com/HindenburgRes\" target=\"_blank\">h says via Twitter </a>that the teledentistry company didn't disclose to potential investors in its IPO filings that the company's stores in California had been \"raided\" as part of an investigation.</li><li>The short-seller wrote, \"The company knew of these raids and that an investigation that taken place in the largest state in the U.S., and investors did not.\"</li><li>The post included an excerpt from a lawsuit filed today by SmileDirect against the Dental Board of California.</li><li><strong>Updates:</strong> In the lawsuit,<a href=\"https://twitter.com/HindenburgRes/status/1184886136612765696\" target=\"_blank\"> attached </a>to a Hindenburg Research tweet, SmileDirect says some of its stores were raided on May 31, 2018; the company<a href=\"https://seekingalpha.com/news/3492515-smiledirectclub-readies-ipo\" target=\"_blank\"> filed a preliminary prospectus</a> for its IPO on Aug. 16, 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506655\" data-linked=\"SmileDirect drops after short-seller tweets about &#39;raids&#39; (updated)\" data-tweet=\"$SDC - SmileDirect drops after short-seller tweets about &#39;raids&#39; (updated) https://seekingalpha.com/news/3506655-smiledirect-drops-after-short-seller-tweets-raids-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3506655-smiledirect-drops-after-short-seller-tweets-raids-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506649\" data-ts=\"1571338989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506649-ibm-teum-and-llnw-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM, TEUM and LLNW among tech movers</a></h4><ul><li><strong>Gainers: </strong>Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network, Inc.'>IPDN</a>) <font color=\"green\">+27%</font>. Limelight Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a>) <font color=\"green\">+21%</font>. Perion Network (NASDAQ:<a href='https://seekingalpha.com/symbol/PERI' title='Perion Network Ltd.'>PERI</a>) <font color=\"green\">+13%</font>. Oi S.A. (NYSE:<a href='https://seekingalpha.com/symbol/OIBR.C' title='Oi S.A.'>OIBR.C</a>) <font color=\"green\">+11%</font>. iCAD (NASDAQ:<a href='https://seekingalpha.com/symbol/ICAD' title='iCAD, Inc.'>ICAD</a>) <font color=\"green\">+9%</font>.</li> <li><strong>Losers: </strong>Pareteum Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"red\">-14%</font>. Jiayin Group (NASDAQ:<a href='https://seekingalpha.com/symbol/JFIN' title='Jiayin Group Inc.'>JFIN</a>) <font color=\"red\">-10%</font>. Leaf Group (NYSE:<a href='https://seekingalpha.com/symbol/LEAF' title='Leaf Group Ltd.'>LEAF</a>) <font color=\"red\">-6%</font>. ClearOne (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRO' title='ClearOne, Inc.'>CLRO</a>) <font color=\"red\">-6%</font>. International Business Machines Corporation (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506649\" data-linked=\"IBM, TEUM and LLNW among tech movers\" data-tweet=\"$IPDN $LLNW $PERI - IBM, TEUM and LLNW among tech movers https://seekingalpha.com/news/3506649-ibm-teum-and-llnw-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506649-ibm-teum-and-llnw-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506647\" data-ts=\"1571338796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CREE\" target=\"_blank\">CREE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506647-creeminus-1_8-piper-expects-downside-surprise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cree -1.8% as Piper expects downside surprise</a></h4><ul><li>Piper Jaffray is \"confident\" that Cree (NASDAQ:<a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a>) will issue a downside guidance when it reports earnings on October 30.</li><li>Analyst Harsh Kumar says the \"broad environment is not improving\" and the Chinese EV market has decelerated over the past few months.</li><li>Kumar: \"Given the lack of clarity around near- term growth, the company\u2019s above industry average multiple might be at risk.\"</li><li>Piper maintains an Underweight rating and $38 price target on the stock. Cree has a Hold average <a href=\"https://seekingalpha.com/symbol/CREE/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Cree shares are <font color=\"red\">down 1.8%</font> to $46.58.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506647\" data-linked=\"Cree -1.8% as Piper expects downside surprise\" data-tweet=\"$CREE - Cree -1.8% as Piper expects downside surprise https://seekingalpha.com/news/3506647-creeminus-1_8-piper-expects-downside-surprise?source=tweet\" data-url=\"https://seekingalpha.com/news/3506647-creeminus-1_8-piper-expects-downside-surprise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506645\" data-ts=\"1571338556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APRN\" target=\"_blank\">APRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506645-blue-apron-breaks-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Apron breaks higher</a></h4><ul> <li>Blue Apron (NYSE:<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>) is now <font color=\"green\">up 10.0%</font> on volume almost 2X normal activity.</li> <li>The break higher in Blue Apron arrives with short interest at an elevated level.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3506645\" data-linked=\"Blue Apron breaks higher\" data-tweet=\"$APRN - Blue Apron breaks higher https://seekingalpha.com/news/3506645-blue-apron-breaks-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3506645-blue-apron-breaks-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506628\" data-ts=\"1571335606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPST\" target=\"_blank\">CPST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506628-capstone-turbineminus-3-on-preliminary-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capstone Turbine -3% on preliminary Q2 results</a></h4><ul><li>Capstone Turbine (<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a> <font color=\"red\">-3.3%</font>) <a href=\"https://seekingalpha.com/pr/17665926-capstone-turbine-reports-select-preliminary-q2-fiscal-2020-financial-results\" target=\"_blank\">announces</a> select preliminary results for 2Q20 ended September 30, 2019.</li><li>Total preliminary revenue was down 7% Y/Y to $20.7M, as the company allocated 1.6 MW of production slots to grow its factory long-term microturbine rental fleet with no production slots allocated to rental units in the year-ago quarter.</li><li>Book-to-bill ratio was 1.0:1, up from 0.7:1 in the year-ago quarter.</li><li>Total cash and cash equivalents are estimated to be $20.9M, compared to $24.6M as of June 30, 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506628\" data-linked=\"Capstone Turbine -3% on preliminary Q2 results\" data-tweet=\"$CPST - Capstone Turbine -3% on preliminary Q2 results https://seekingalpha.com/news/3506628-capstone-turbineminus-3-on-preliminary-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3506628-capstone-turbineminus-3-on-preliminary-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506624\" data-ts=\"1571335299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506624-carbo-ceramics-and-ring-energy-among-energy-materials-gainers-insteel-industries-and-key\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CARBO Ceramics and Ring Energy among Energy/Materials gainers; Insteel Industries and Key Energy Services among losers</a></h4><ul><li><b>Gainers: </b>CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"green\">+23%</font>. Ring Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/REI' title='Ring Energy, Inc.'>REI</a>) <font color=\"green\">+12%</font>. Sierra Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/SMTS' title='Sierra Metals Inc.'>SMTS</a>) <font color=\"green\">+11%</font>. Gold Resource GORO <font color=\"green\">+9%</font>. Trilogy Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/TMQ' title='Trilogy Metals Inc.'>TMQ</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Insteel Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/IIIN' title='Insteel Industries, Inc.'>IIIN</a>) <font color=\"red\">-10%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-8%</font>. Nabors Industries (NYSE:<a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a>) <font color=\"red\">-7%</font>. Valaris (NYSE:<a href='https://seekingalpha.com/symbol/VAL' title='Valaris plc'>VAL</a>) <font color=\"red\">-7%</font>. Extraction Oil &amp; Gas (NASDAQ:<a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas, Inc.'>XOG</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506624\" data-linked=\"CARBO Ceramics and Ring Energy among Energy/Materials gainers; Insteel Industries and Key Energy Services among losers\" data-tweet=\"$CRR $REI $SMTS - CARBO Ceramics and Ring Energy among Energy/Materials gainers; Insteel Industries and Key Energy Services among losers https://seekingalpha.com/news/3506624-carbo-ceramics-and-ring-energy-among-energy-materials-gainers-insteel-industries-and-key?source=tweet\" data-url=\"https://seekingalpha.com/news/3506624-carbo-ceramics-and-ring-energy-among-energy-materials-gainers-insteel-industries-and-key\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506619\" data-ts=\"1571334604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EAT\" target=\"_blank\">EAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506619-brinkerplus-2-after-raymond-james-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brinker +2% after Raymond James nod</a></h4><ul> <li>Brinker International (<a href='https://seekingalpha.com/symbol/EAT' title='Brinker International, Inc.'>EAT</a> <font color='green'>+2.1%</font>) gains after Raymond James calls out the chain as one its favorites from the restaurant sector.</li> <li>Raymond James elevated Brinker to a top long idea on the same day it took Cheesecake Factory <a href=\"https://seekingalpha.com/news/3506499-cheesecake-factory-minus-2-percent-raymond-james-cut\" target=\"_blank\">down</a> a notch.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3506619\" data-linked=\"Brinker +2% after Raymond James nod\" data-tweet=\"$EAT - Brinker +2% after Raymond James nod https://seekingalpha.com/news/3506619-brinkerplus-2-after-raymond-james-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3506619-brinkerplus-2-after-raymond-james-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506618\" data-ts=\"1571334275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFED\" target=\"_blank\">GFED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506618-guaranty-federal-bancshares-eps-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guaranty Federal Bancshares EPS beats by $0.01, beats on revenue</a></h4><ul><li>Guaranty Federal Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/GFED' title='Guaranty Federal Bancshares, Inc.'>GFED</a>): Q3 GAAP EPS of $0.57 <font color=\"green\">beats by $0.01</font>.</li><li>Revenue of $10.06M (-17.5% Y/Y) <font color=\"green\">beats by $0.16M</font>.</li><li>Shares <font color=\"green\">+3%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17666083-guaranty-federal-bancshares-inc-reaches-1-billion-total-assets-announces-preliminary-third\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3506618\" data-linked=\"Guaranty Federal Bancshares EPS beats by $0.01, beats on revenue\" data-tweet=\"$GFED - Guaranty Federal Bancshares EPS beats by $0.01, beats on revenue https://seekingalpha.com/news/3506618-guaranty-federal-bancshares-eps-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3506618-guaranty-federal-bancshares-eps-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506614\" data-ts=\"1571333527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506614-sinclair-and-t-reach-sports-local-carriage-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair, AT&amp;T reach sports/local carriage deal</a></h4><ul>   <li>Sinclair Broadcast Group (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color=\"green\">+2.4%</font>) and AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"green\">+0.1%</font>) have reached a multi-year carriage agreement that keeps Sinclair stations on DirecTV, AT&amp;T TV and U-verse.</li>    <li>The deal covers Sinclair's owned local broadcast stations and the Tennis Channel.</li>    <li>It also covers Sinclair's recently acquired 21 regional sports networks along with the YES Network (in which Sinclair is a JV partner), and future carriage of Marquee Sports Network, an RSN launching in 2020 featuring Chicago Cubs games.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3506614\" data-linked=\"Sinclair, AT&amp;T reach sports/local carriage deal\" data-tweet=\"$SBGI $T - Sinclair, AT&amp;T reach sports/local carriage deal https://seekingalpha.com/news/3506614-sinclair-and-t-reach-sports-local-carriage-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3506614-sinclair-and-t-reach-sports-local-carriage-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506613\" data-ts=\"1571333485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBT\" target=\"_blank\">BBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506613-bb-and-t-suntrust-slip-after-q3-results-underwhelm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BB&amp;T, SunTrust slip after Q3 results underwhelm</a></h4><ul><li>BB&amp;T (<a href='https://seekingalpha.com/symbol/BBT' title='BB&T Corporation'>BBT</a> <font color='red'>-1.7%</font>) and SunTrust (<a href='https://seekingalpha.com/symbol/STI' title='SunTrust Banks, Inc.'>STI</a> <font color='red'>-1.7%</font>) both fall after Q3 earnings disappointed.</li><li>The two banks that in February agreed to merge reported charges related to the pending union -- BB&amp;T recorded $26M in after-tax merger-related and restructuring charges plus $40M of after-tax incremental operating expenses related to the deal; SunTrust recorded $33M of merger-related costs.</li><li>For BB&amp;T, \"NII and credit are better, but core fees and core costs are worse,\" writes Jefferies analyst Ken Usdin.</li><li>The bank's guidance for Q4 implies standalone EPS of $1.00-$1.05 \"with some moving parts,\" Usdin writes.</li><li>Compares with average analyst estimate of $1.05.</li><li>For SunTrust, NII fell 2% Q/Q and NIM contracted by 10 basis points to 3.06%%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506613\" data-linked=\"BB&amp;T, SunTrust slip after Q3 results underwhelm\" data-tweet=\"$BBT $STI $TFC - BB&amp;T, SunTrust slip after Q3 results underwhelm https://seekingalpha.com/news/3506613-bb-and-t-suntrust-slip-after-q3-results-underwhelm?source=tweet\" data-url=\"https://seekingalpha.com/news/3506613-bb-and-t-suntrust-slip-after-q3-results-underwhelm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506606\" data-ts=\"1571333033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASMB\" target=\"_blank\">ASMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506606-assembly-bio-up-45-on-encouraging-data-on-hbv-candidates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Assembly Bio up 45% on encouraging data on HBV candidates</a></h4><ul><li>Thinly traded micro cap Assembly Biosciences (<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a> <font color=\"green\">+45.4%</font>) is up on a 13x surge in volume. Shares have almost doubled in two days in response to <a href=\"https://seekingalpha.com/pr/17663986-safety-antiviral-activity-assembly-biosciences-first-second-generation-core-inhibitor\" target=\"_blank\">positive data</a> on HBV candidates ABI-H0731 and ABI-H2158. The results will be presented at The Liver Meeting in Boston next month.</li><li>Final results from a Phase 2a study of lead candidate ABI-H0731 + nucleoside/tide analogs (Nrtl) in Hbe antigen-positive HBV patients showed faster and greater declines in HBV DNA and RNA compared to Nrtl alone.</li><li>Preliminary results from a Phase 1b trial evaluating candidate #2 ABI-H2158 alone in Hbe antigen-positive HBV patients showed declines in HBV DNA and RNA after 14 days of treatment with a favorable safety profile.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506606\" data-linked=\"Assembly Bio up 45% on encouraging data on HBV candidates\" data-tweet=\"$ASMB - Assembly Bio up 45% on encouraging data on HBV candidates https://seekingalpha.com/news/3506606-assembly-bio-up-45-on-encouraging-data-on-hbv-candidates?source=tweet\" data-url=\"https://seekingalpha.com/news/3506606-assembly-bio-up-45-on-encouraging-data-on-hbv-candidates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506609\" data-ts=\"1571332120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506609-endo-adds-to-opioid-settlement-stoked-rally-up-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endo adds to opioid settlement-stoked rally, up 16%</a></h4><ul><li>Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"green\">+15.7%</font>) is up on almost triple normal volume, adding to its <font color=\"green\">19%</font> jump yesterday as investors buy in expecting a workable broad settlement with state and local governments over its role in the opioid epidemic.</li><li>Citron Research has added to the renewed animal spirits with a <a href=\"https://twitter.com/CitronResearch?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\" target=\"_blank\">tweet </a>stating that the stock could reach $10 by Monday.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506609\" data-linked=\"Endo adds to opioid settlement-stoked rally, up 16%\" data-tweet=\"$ENDP - Endo adds to opioid settlement-stoked rally, up 16% https://seekingalpha.com/news/3506609-endo-adds-to-opioid-settlement-stoked-rally-up-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3506609-endo-adds-to-opioid-settlement-stoked-rally-up-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506607\" data-ts=\"1571331818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNSDF\" target=\"_blank\">RNSDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506607-renault-lowers-full-year-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Renault lowers full-year outlook</a></h4><ul> <li>Renault (<a href='https://seekingalpha.com/symbol/RNSDF' title='Renault SA'>OTC:RNSDF</a>) expects revenue to fall off 3% to 4% this year in a <a href=\"https://media.group.renault.com/global/en-gb/groupe-renault/media/pressreleases/21234773/le-groupe-renault-revise-ses-objectifs-annuels-2019-et-preannonce-son-chiffre-daffaires-du-3eme-trim\" target=\"_blank\">sharp downward slash</a> from its prior forecast for around flat growth.</li> <li>The French automaker also lowers its full year operating margin guidance to 5% from 6%.</li> <li>Automotive operating free cash flow is anticipated be positive in H2 while not guaranteed for the full year vs. previous guidance for positive full-year automotive operational free cash flow.</li> <li>Renault closed <font color=\"red\">down 0.47%</font> in Paris before the financial update.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506607\" data-linked=\"Renault lowers full-year outlook\" data-tweet=\"$RNSDF - Renault lowers full-year outlook https://seekingalpha.com/news/3506607-renault-lowers-full-year-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3506607-renault-lowers-full-year-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506605\" data-ts=\"1571331697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506605-nf-energy-saving-and-loma-negra-compania-among-industrial-gainers-ideal-power-and-hovnanian\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NF Energy Saving and Loma Negra Compania among Industrial gainers; Ideal Power and Hovnanian Enterprises among losers</a></h4><ul><li><b>Gainers: </b>NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"green\">+14%</font>. Loma Negra Compania Industrial Argentina Sociedad Anonima (NYSE:<a href='https://seekingalpha.com/symbol/LOMA' title='Loma Negra Compañía Industrial Argentina Sociedad Anónima'>LOMA</a>) <font color=\"green\">+6%</font>. U.S. Concrete (NASDAQ:<a href='https://seekingalpha.com/symbol/USCR' title='U.S. Concrete, Inc.'>USCR</a>) <font color=\"green\">+5%</font>. Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"red\">-17%</font>. Hovnanian Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a>) <font color=\"red\">-13%</font>. Textron (NYSE:<a href='https://seekingalpha.com/symbol/TXT' title='Textron Inc.'>TXT</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506605\" data-linked=\"NF Energy Saving and Loma Negra Compania among Industrial gainers; Ideal Power and Hovnanian Enterprises among losers\" data-tweet=\"$BIMI $LOMA $USCR - NF Energy Saving and Loma Negra Compania among Industrial gainers; Ideal Power and Hovnanian Enterprises among losers https://seekingalpha.com/news/3506605-nf-energy-saving-and-loma-negra-compania-among-industrial-gainers-ideal-power-and-hovnanian?source=tweet\" data-url=\"https://seekingalpha.com/news/3506605-nf-energy-saving-and-loma-negra-compania-among-industrial-gainers-ideal-power-and-hovnanian\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506602\" data-ts=\"1571331180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506602-clipper-realty-leads-financial-gainers-hexindai-and-mmtec-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clipper Realty leads financial gainers; Hexindai and Mmtec among losers</a></h4><ul><li><b>Gainers:</b> Clipper Realty (NYSE:<a href='https://seekingalpha.com/symbol/CLPR' title='Clipper Realty Inc.'>CLPR</a>) <font color=\"green\">+6%</font>. MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"green\">+5%</font>. RLI (NYSE:<a href='https://seekingalpha.com/symbol/RLI' title='RLI Corp.'>RLI</a>) <font color=\"green\">+5%</font>. eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> Provident Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/PVBC' title='Provident Bancorp, Inc.'>PVBC</a>) <font color=\"red\">-51%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"red\">-19%</font>. Mmtec (NASDAQ:<a href='https://seekingalpha.com/symbol/MTC' title='Mmtec, Inc.'>MTC</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506602\" data-linked=\"Clipper Realty leads financial gainers; Hexindai and Mmtec among losers\" data-tweet=\"$CLPR $MGI $RLI - Clipper Realty leads financial gainers; Hexindai and Mmtec among losers https://seekingalpha.com/news/3506602-clipper-realty-leads-financial-gainers-hexindai-and-mmtec-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506602-clipper-realty-leads-financial-gainers-hexindai-and-mmtec-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506601\" data-ts=\"1571330805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506601-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers: </strong>Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"green\">+64%</font>. Assembly Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a>) <font color=\"green\">+41%</font>. Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network, Inc.'>IPDN</a>) <font color=\"green\">+31%</font>. Synthesis Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/SES' title='Synthesis Energy Systems, Inc.'>SES</a>) <font color=\"green\">+23%</font>. Limelight Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a>) <font color=\"green\">+21%</font>. CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"green\">+21%</font>. Endo International (NASDAQ:<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a>) <font color=\"green\">+18%</font>. Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology, Inc.'>CLVS</a>) <font color=\"green\">+15%</font>. Castor Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRM' title='Castor Maritime Inc.'>CTRM</a>) <font color=\"green\">+15%</font>. HEXO (NYSE:<a href='https://seekingalpha.com/symbol/HEXO' title='HEXO Corp.'>HEXO</a>) <font color=\"green\">+13%</font>.</li> <li><strong>Losers: </strong>Provident Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/PVBC' title='Provident Bancorp, Inc.'>PVBC</a>) <font color=\"red\">-51%</font>. Waitr Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WTRH' title='Waitr Holdings Inc.'>WTRH</a>) <font color=\"red\">-47%</font>. Bionano Genomics (NASDAQ:<a href='https://seekingalpha.com/symbol/BNGO' title='Bionano Genomics, Inc.'>BNGO</a>) <font color=\"red\">-42%</font>. Syros Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SYRS' title='Syros Pharmaceuticals, Inc.'>SYRS</a>) <font color=\"red\">-32%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"red\">-18%</font>. Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"red\">-17%</font>. Diffusion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a>) <font color=\"red\">-15%</font>. Viveve Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a>) <font color=\"red\">-14%</font>. TDH Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a>) <font color=\"red\">-14%</font>. Hovnanian Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a>) <font color=\"red\">-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506601\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$HEPA $ASMB $IPDN - Microcaps mostly among midday movers https://seekingalpha.com/news/3506601-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506601-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506600\" data-ts=\"1571330298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506600-stocks-pare-gains-earnings-roll-in-brexit-spirits-flag\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks pare gains as earnings roll in, Brexit spirits flag</a></h4><ul><li>The three major U.S. stock averages waver from their session highs, which weren't too far off of all-time highs.</li><li>Spirits that rose after the U.K. and EU reached a Brexit deal dimmed when a key Northern Irish political party said it won't vote for the deal.</li><li>Most earnings are rolling in on the better-than-expected side, though IBM and Union Pacific disappointed.</li><li>The S&amp;P 500, which broke above 3,000 earlier to within 0.6% of the index's intraday high, is <font color=\"green\">up 0.2%</font>.</li><li>The Nasdaq, <font color=\"green\">up 0.3%</font>, had risen as much as 0.7% earlier; the Dow is flat compared with a 0.4% rise early in the session.</li><li>10-year Treasury gains, pushing yield down 1 basis point to 1.734%.</li><li>Across the Atlantic, equities ended the session mixed; Stoxx Europe 600 closed <font color=\"red\">down 0.1%</font>, Germany's DAX <font color=\"red\">fell 0.1%</font>, U.K.'s FTSE 100 Index ended the session <font color=\"green\">up 0.2%</font>, and France's CAC 40 Index closed <font color=\"red\">down 0.4%</font>.</li><li>In U.S. markets, health care (<font color=\"green\">+0.8%</font>), industrials (<font color=\"green\">+0.6%</font>), and real estate (<font color=\"green\">+0.6%</font>) exhibit the most strength among S&amp;P 500 industry sectors, while information technology (<font color=\"red\">-0.6%</font>) and energy (<font color=\"red\">-0.2%</font>) lag.</li><li>Crude oil<font color=\"red\"> falls 0.7%</font> to 52.98.</li><li>Dollar Index<font color=\"red\"> slides 0.4%</font> to 97.61.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506600\" data-linked=\"Stocks pare gains as earnings roll in, Brexit spirits flag\" data-tweet=\"Stocks pare gains as earnings roll in, Brexit spirits flag https://seekingalpha.com/news/3506600-stocks-pare-gains-earnings-roll-in-brexit-spirits-flag?source=tweet\" data-url=\"https://seekingalpha.com/news/3506600-stocks-pare-gains-earnings-roll-in-brexit-spirits-flag\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506595\" data-ts=\"1571328850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506595-central-european-media-rallies-9-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Central European Media rallies 9% post Q3 results</a></h4><ul><li>Central European Media (<a href='https://seekingalpha.com/symbol/CETV' title='Central European Media Enterprises Ltd.'>CETV</a> <font color=\"green\">+9%</font>) reported <a href=\"https://seekingalpha.com/pr/17665391-central-european-media-enterprises-ltd-reports-results-third-quarter-nine-months-ended\" target=\"_blank\">Q3</a> revenue growth of 1.3% Y/Y and 7% at constant rates to $138.9M.</li><li>TV advertising revenues decreased 3% at actual rates, but increased 4% at constant rates.</li><li>Carriage fees and subscription revenues increased 4% Y/Y at actual rates and 11% at constant rates.</li><li>Costs charged in arriving at OIBDA decreased 8% Y/Y at actual rates and 1% at constant rates.</li><li>Operating margin <font color=\"green\">increased 600 bps</font> to 22.2% &amp; OIBDA margin <font color=\"green\">increased 490 bps</font> to 33%.</li><li>Cash generated from continuing operating activities increased 79% Y/Y at $168M.</li><li>Unlevered FCF increased 25% Y/Y to $170.6M.</li><li>The company repaid a total of \u20ac150M of debt in 2019 using cash generated by the business.</li><li>Net leverage ratio declined to 2.5x at the end of September, down from 3.5x at the start of the year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506381-central-european-media-beats-revenue\" target=\"_blank\">Central European Media beats on revenue</a> (Oct. 17 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506595\" data-linked=\"Central European Media rallies 9% post Q3 results\" data-tweet=\"$CETV - Central European Media rallies 9% post Q3 results https://seekingalpha.com/news/3506595-central-european-media-rallies-9-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3506595-central-european-media-rallies-9-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506592\" data-ts=\"1571328432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506592-tata-motors-leads-consumer-gainers-new-age-beverages-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tata Motors leads consumer gainers; New Age Beverages among losers</a></h4><ul><li><b>Gainers: </b>Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) <font color=\"green\">+10%</font>. Pool (NASDAQ:<a href='https://seekingalpha.com/symbol/POOL' title='Pool Corporation'>POOL</a>) <font color=\"green\">+8%</font>. Crown Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CCK' title='Crown Holdings, Inc.'>CCK</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>TDH Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a>) <font color=\"red\">-13%</font>. Purple Innovation (NASDAQ:<a href='https://seekingalpha.com/symbol/PRPL' title='Purple Innovation, Inc.'>PRPL</a>) <font color=\"red\">-8%</font>. New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506592\" data-linked=\"Tata Motors leads consumer gainers; New Age Beverages among losers\" data-tweet=\"$TTM $POOL $CCK - Tata Motors leads consumer gainers; New Age Beverages among losers https://seekingalpha.com/news/3506592-tata-motors-leads-consumer-gainers-new-age-beverages-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506592-tata-motors-leads-consumer-gainers-new-age-beverages-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506590\" data-ts=\"1571328152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOG\" target=\"_blank\">XOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506590-extraction-oil-tanks-following-imperials-double-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Extraction Oil tanks following Imperial&#39;s double downgrade</a></h4><ul><li>Extraction Oil and Gas (<a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas, Inc.'>XOG</a> <font color='red'>-10.2%</font>) slumps to a 52-week low as Imperial Capital <a href=\"https://thefly.com/thestreet/realmoney/index.php/XOGid2976537/XOG-Extraction-Oil-downgraded-to-Underperform-from-Outperform-at-Imperial-Capital\" target=\"_blank\">downgrades</a> shares to Underperform from Outperform with a $2 price target, slashed from $7, saying the company's business model is \"fundamentally more risky\" than other DJ Basin peers.</li><li>Imperial analyst Irene Haas expects Q3 production will be flat due to unplanned outages on the Western Gas system and a two-month delay in the startup of the Rimrock system.</li><li>With the recent departure of its CFO, Haas also is concerned that  XOG \"might not be equipped to weather additional commodity  prices downdraft or operational upsets, planned or unplanned.\"</li><li>Stephens analyst Gail Nicholson yesterday <a href=\"https://thefly.com/thestreet/realmoney/index.php/XOGid2975931/XOG-Extraction-Oil--Gas-downgraded-to-Equal-Weight-from-Overweight-at-Stephens\" target=\"_blank\">cut XOG to  Equal Weight</a> from Overweight with a $4 price target, driven by the Q3 production miss and increased cautiousness around oil.</li><li>XOG's average <a href=\"https://seekingalpha.com/symbol/XOG/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform, and its <a href=\"https://seekingalpha.com/symbol/XOG/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> is Bullish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506590\" data-linked=\"Extraction Oil tanks following Imperial&#39;s double downgrade\" data-tweet=\"$XOG - Extraction Oil tanks following Imperial&#39;s double downgrade https://seekingalpha.com/news/3506590-extraction-oil-tanks-following-imperials-double-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3506590-extraction-oil-tanks-following-imperials-double-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506585\" data-ts=\"1571327750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHHBY\" target=\"_blank\">RHHBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506585-fda-oks-expanded-use-of-roche-flu-med-xofluza\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs expanded use of Roche flu med Xofluza</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17666435-genentech-announces-fda-approval-xofluza-baloxavir-marboxil-people-high-risk-developing\" target=\"_blank\">approves </a>Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding AG'>OTCQX:RHHBY</a> <font color=\"green\">+2%</font>) unit Genentech's supplemental marketing application for Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza in people at least 12 years old who have been symptomatic for no more than 48 hours and are at high risk of developing flu-related complications.</li><li>The agency first approved the polymerase acidic endonuclease inhibitor a year ago for the acute treatment of uncomplicated flu in otherwise healthy people at least 12 years old who have been symptomatic for no more than 48 hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506585\" data-linked=\"FDA OKs expanded use of Roche flu med Xofluza\" data-tweet=\"$RHHBY - FDA OKs expanded use of Roche flu med Xofluza https://seekingalpha.com/news/3506585-fda-oks-expanded-use-of-roche-flu-med-xofluza?source=tweet\" data-url=\"https://seekingalpha.com/news/3506585-fda-oks-expanded-use-of-roche-flu-med-xofluza\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506584\" data-ts=\"1571327697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTWO\" target=\"_blank\">TTWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506584-mkm-unconcerned-borderlands-3-discounts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MKM unconcerned about &#39;Borderlands 3&#39; discounts</a></h4><ul>   <li>Don't be worried about retail discounts for the recently released <i>Borderlands 3,</i> MKM says in a new note on Take-Two Interactive Software (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color=\"green\">+1.7%</font>).</li>    <li>Those are tied to marketing rather than performance, and the game has \"continued to sell well,\" says analyst Eric Handler.</li>    <li>He notes that while some retailers discounted the game, major retailers like GameStop and Amazon.com are selling it at full price. And 30-day price protection for <i>Borderlands 3</i> ended yesterday following its mid-September launch, he notes.</li>    <li>The game was the <a href=\"https://seekingalpha.com/news/3501197-borderlands-3-passes-5m-units-five-days-sale\" target=\"_blank\">fastest-selling title at launch</a> in Take-Two's history.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506584\" data-linked=\"MKM unconcerned about &#39;Borderlands 3&#39; discounts\" data-tweet=\"$TTWO - MKM unconcerned about &#39;Borderlands 3&#39; discounts https://seekingalpha.com/news/3506584-mkm-unconcerned-borderlands-3-discounts?source=tweet\" data-url=\"https://seekingalpha.com/news/3506584-mkm-unconcerned-borderlands-3-discounts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506579\" data-ts=\"1571327118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HT\" target=\"_blank\">HT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506579-bmo-starts-hersha-coverage-bear\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMO starts Hersha coverage as a bear</a></h4><ul><li>Hersha Hospitality (<a href='https://seekingalpha.com/symbol/HT' title='Hersha Hospitality Trust'>HT</a> <font color='red'>-1.2%</font>) <font color=\"red\">falls 1.2%</font> after BMO analyst Ari Klein initiates coverage of the REIT with an underperform rating due to Hersha's high exposure to the \"challenging\" New York City market.</li><li>Klein picks up coverage of six hotel REITs and two hotel operators.</li><li>Current environment is uncertain with few signs of a near-term pivot, but sees the tide turning eventually \"as the economy's footing becomes more certain.\"</li><li>Rates Hilton (<a href='https://seekingalpha.com/symbol/HLT' title='Hilton Worldwide Holdings Inc.'>HLT</a> <font color='green'>+0.3%</font>) and Host Hotels &amp; Resorts (<a href='https://seekingalpha.com/symbol/HST' title='Host Hotels & Resorts, Inc.'>HST</a> <font color='green'>+0.3%</font>) outperform.</li><li>Marriott International (<a href='https://seekingalpha.com/symbol/MAR' title='Marriott International, Inc.'>MAR</a> <font color='red'>-0.2%</font>), Pebblebrook Hotel Trust (<a href='https://seekingalpha.com/symbol/PEB' title='Pebblebrook Hotel Trust'>PEB</a> <font color='red'>-0.8%</font>), Park Hotels &amp; Resorts (<a href='https://seekingalpha.com/symbol/PK' title='Park Hotels & Resorts Inc.'>PK</a> <font color='red'>-2%</font>), Xenia Hotels &amp; Resorts (<a href='https://seekingalpha.com/symbol/XHR' title='Xenia Hotels & Resorts, Inc.'>XHR</a> <font color='red'>-3.4%</font>), and Chatham Lodging Trust (<a href='https://seekingalpha.com/symbol/CLDT' title='Chatham Lodging Trust'>CLDT</a> <font color='red'>-0.2%</font>) get a market perform rating.</li><li>Hersha is the only one Klein rates underperform.</li><li>via Bloomberg.</li><li>Before this action, Sell-Side average rating for Hersha was <a href=\"https://seekingalpha.com/symbol/HT/ratings/sell-side-ratings\" target=\"_blank\">Hold</a> (1 Buy, 6 Hold, 5 Underperform).</li></ul><div class=\"tiny-share-widget\" data-id=\"3506579\" data-linked=\"BMO starts Hersha coverage as a bear\" data-tweet=\"$HT $HLT $HST - BMO starts Hersha coverage as a bear https://seekingalpha.com/news/3506579-bmo-starts-hersha-coverage-bear?source=tweet\" data-url=\"https://seekingalpha.com/news/3506579-bmo-starts-hersha-coverage-bear\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506569\" data-ts=\"1571326026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GORO\" target=\"_blank\">GORO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506569-gold-resources-gold-production-hit-quarterly-record-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Resource&#39;s gold production hit quarterly record in Q3</a></h4><ul><li>Gold Resource Corp. (<a href='https://seekingalpha.com/symbol/GORO' title='Gold Resource Corporation'>GORO</a> <font color='green'>+6.5%</font>) reports preliminary <a href=\"https://seekingalpha.com/pr/17665676-gold-resource-corporation-reports-record-third-quarter-gold-production-increases-2019-annual\" target=\"_blank\">record Q3 gold production</a> of 11,165 oz., reflecting increased output at its Isabella Pearl mine in Nevada, and raises its full-year gold production outlook by 42% to 38.4K gold oz. at the midpoint.</li><li>GORO says preliminary Q3 production from its Oaxaca mine in Mexico totaled nearly 7.5K oz. of gold and 473K oz. of silver, and maintains its full-year production outlook for the mine at 27K gold oz. and 1.7M silver oz.</li><li>The company says its Isabella Pearl mine has produced 5,381 oz. of gold since producing first gold in April 2019, and forecasts Q4 gold output for the mine at 6K oz.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506569\" data-linked=\"Gold Resource&#39;s gold production hit quarterly record in Q3\" data-tweet=\"$GORO - Gold Resource&#39;s gold production hit quarterly record in Q3 https://seekingalpha.com/news/3506569-gold-resources-gold-production-hit-quarterly-record-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3506569-gold-resources-gold-production-hit-quarterly-record-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506568\" data-ts=\"1571325912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506568-specialty-retail-catches-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Specialty retail catches a bid</a></h4><ul> <li>Select specialty retailers getting more than just a passing glance from investors just head of the earnings season ramp-up.</li> <li>Notable gainers include Barnes &amp; Noble Education (<a href='https://seekingalpha.com/symbol/BNED' title='Barnes & Noble Education, Inc.'>BNED</a> <font color='green'>+4.9%</font>), Stitch Fix (<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a> <font color='green'>+5.6%</font>), Blue Apron (<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a> <font color='green'>+3.7%</font>), Etsy (<a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a> <font color='green'>+2.4%</font>), Qurate Retail QRTEA, Francesca's FRAN, Wayfair (<a href='https://seekingalpha.com/symbol/W' title='Wayfair Inc.'>W</a> <font color='green'>+6.2%</font>), The Container Store (<a href='https://seekingalpha.com/symbol/TCS' title='The Container Store Group, Inc.'>TCS</a> <font color='green'>+2%</font>) and Express (<a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color='green'>+4.7%</font>).</li> <li>The gains for the group of specialty retailers stand above the modest 0.85% rise of the SPDR S&amp;P Retail ETF, which consists of larger companies.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506568\" data-linked=\"Specialty retail catches a bid\" data-tweet=\"$BNED $SFIX $APRN - Specialty retail catches a bid https://seekingalpha.com/news/3506568-specialty-retail-catches-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3506568-specialty-retail-catches-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506566\" data-ts=\"1571325704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506566-wns-rallies-7_2-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WNS rallies 7.2% post Q2 results</a></h4><ul><li>WNS (<a href='https://seekingalpha.com/symbol/WNS' title='WNS &#40;Holdings&#41; Limited'>WNS</a> <font color=\"green\">+7.2%</font>) reports <a href=\"https://seekingalpha.com/pr/17665495-wns-announces-fiscal-2020-second-quarter-earnings-revises-full-year-guidance\" target=\"_blank\">Q2</a> revenue increase of 12.9% Y/Y to $220.7M.</li><li>Operating margin <font color=\"green\">increased 160 bps</font> to 16.1% and adj. operating margin <font color=\"green\">increased 250 bps</font> to 23.5%.</li><li>Q2 ended with $223.8M in cash and investments and $47.5M of debt.</li><li>WNS added 6 new clients in Q2, expanded 9 existing relationships.</li><li>Global headcount was 42,602 as of September 30, 2019.</li><li>\u201cOur guidance for the year reflects growth in revenue less repair payments of 8% to 12%, or 10% to 14% on a constant currency basis and have over 98% visibility to the midpoint of the range.\u201d said Sanjay Puria, WNS\u2019s CFO.</li><li><b>2020 Guidance:</b> Adj. revenue expected to be $861-892M; ANI is expected between $152-160M &amp; based on a diluted share count of 51.9M shares, the company expects adj. EPADS of $2.93-$3.08.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506400-wns-eps-beats-0_12-beats-revenue\" target=\"_blank\">WNS EPS beats by $0.12, beats on revenue</a> (Oct. 17 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506566\" data-linked=\"WNS rallies 7.2% post Q2 results\" data-tweet=\"$WNS - WNS rallies 7.2% post Q2 results https://seekingalpha.com/news/3506566-wns-rallies-7_2-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3506566-wns-rallies-7_2-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506562\" data-ts=\"1571324856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506562-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"green\">+94%</font>. Assembly Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a>) <font color=\"green\">+22%</font>. Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) <font color=\"green\">+20%</font>. Endo International (NASDAQ:<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a>) <font color=\"green\">+17%</font>. Mallinckrodt (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Bionano Genomics (NASDAQ:<a href='https://seekingalpha.com/symbol/BNGO' title='Bionano Genomics, Inc.'>BNGO</a>) <font color=\"red\">-37%</font>. Syros Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SYRS' title='Syros Pharmaceuticals, Inc.'>SYRS</a>) <font color=\"red\">-28%</font>. Viveve Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a>) <font color=\"red\">-17%</font>. Diffusion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a>) <font color=\"red\">-12%</font>. Aytu BioScience (NASDAQ:<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a>) <font color=\"red\">-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506562\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$HEPA $ASMB $CANF - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3506562-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506562-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506561\" data-ts=\"1571324456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506561-crude-inventories-build-sharply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude inventories build sharply</a></h4><ul><li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>: Crude <strong>+9.3M</strong> barrels vs. +2.9M consensus, +2.9M last week.</li><li>Gasoline <strong>-2.6M</strong> barrels vs. -1.4M consensus, -1.2M last week.</li><li>Distillates <strong>-3.8M</strong> barrels vs. -2.4M consensus, -3.9M last week.</li><li>Futures <font color=\"red\">-0.41%</font> to $53.14.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P GSCI Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Trust II - ProShares Ultra Bloomberg Crude Oil'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='United States Brent Oil Fund, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='United States 12 Month Oil Fund, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506561\" data-linked=\"Crude inventories build sharply\" data-tweet=\"$USO $OIL $UCO - Crude inventories build sharply https://seekingalpha.com/news/3506561-crude-inventories-build-sharply?source=tweet\" data-url=\"https://seekingalpha.com/news/3506561-crude-inventories-build-sharply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506558\" data-ts=\"1571324205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERIC\" target=\"_blank\">ERIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506558-ericssonplus-7_2-5g-demand-drives-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ericsson +7.2% as 5G demand drives Q3 beat</a></h4><ul>   <li>Ericsson (NASDAQ:<a href='https://seekingalpha.com/symbol/ERIC' title='Telefonaktiebolaget LM Ericsson &#40;publ&#41;'>ERIC</a>) is <font color=\"green\">up 7.2%</font> in Nasdaq trading after it topped expectations with <a href=\"https://seekingalpha.com/news/3506383-telefonaktiebolaget-lm-ericsson-beats-revenue\" target=\"_blank\">Q3 earnings</a> and raised its guidance on stronger than expected 5G demand.</li>    <li>Sales rose 6% to 57.1B Swedish kronor; adjusting for comparable units and currency meant a gain of 3%, driven by growth in North America and Northeast Asia.</li>    <li>Adjusted operating income was 6.5B kronor, with a margin of 11.4%.</li>    <li>CEO Borje Ekholm says \"5G is taking off faster than earlier anticipated and we see initial 5G buildout as a capacity enhancer in metropolitan areas. However, over time, new exciting innovations for 5G will come with industrial and IoT use cases, leveraging the speed, latency and security characteristics of 5G.\"</li>    <li>The company now says it's forecasting 2020 sales of 230B-240B kronor (about $23.5B-$24.5B), up from the previous guidance for 210B-220B kronor. It's affirming an operating margin target of over 10% of sales for 2020, and 12-14% for 2022 (up from a previous \"greater than 12%\").</li>    <li>Free cash flow (excluding M&amp;A) was 5.5B kronor, and net cash increased to 37.4B kronor.</li>     <li><a href=\"https://seekingalpha.com/article/4297017-telefonaktiebolaget-lm-ericsson-eric-ceo-borje-ekholm-q3-2019-results-earnings-call\" target=\"_blank\">Earnings call transcript</a></li>   <li><a href=\"https://seekingalpha.com/pr/17665389-ericsson-reports-third-quarter-results-2019\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3506558\" data-linked=\"Ericsson +7.2% as 5G demand drives Q3 beat\" data-tweet=\"$ERIC - Ericsson +7.2% as 5G demand drives Q3 beat https://seekingalpha.com/news/3506558-ericssonplus-7_2-5g-demand-drives-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3506558-ericssonplus-7_2-5g-demand-drives-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506556\" data-ts=\"1571323825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTNX\" target=\"_blank\">NTNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506556-nutanix-bull-sees-sales-turnaround-sharesplus-1_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nutanix bull sees sales turnaround; shares +1.5%</a></h4><ul><li>William Blair says Nutanix's (NASDAQ:<a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix, Inc.'>NTNX</a>) North American business \"looks to be on the rebound.\"</li><li>Analyst Jason Ader cites value-added reseller contacts who \"were meaningfully more upbeat on their business with Nutanix\" than in H1.</li><li>Ader attributes the turnaround to improved execution under new sales head Chris Kaddara.</li><li>William Blair has an Outperform rating on Nutanix. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/NTNX/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Nutanix shares are <font color=\"green\">up 1.5%</font> to $26.57.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506556\" data-linked=\"Nutanix bull sees sales turnaround; shares +1.5%\" data-tweet=\"$NTNX - Nutanix bull sees sales turnaround; shares +1.5% https://seekingalpha.com/news/3506556-nutanix-bull-sees-sales-turnaround-sharesplus-1_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3506556-nutanix-bull-sees-sales-turnaround-sharesplus-1_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506555\" data-ts=\"1571323792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYRS\" target=\"_blank\">SYRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506555-syros-pharma-bails-on-cancer-candidate-syminus-1365-shares-down-28\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syros Pharma bails on cancer candidate SY-1365; shares down 28%</a></h4><ul><li>Citing the greater anti-tumor activity of CDK7 inhibitor SY-5609 and its more flexible oral route of administration, Syros Pharmaceuticals (<a href='https://seekingalpha.com/symbol/SYRS' title='Syros Pharmaceuticals, Inc.'>SYRS</a> <font color=\"red\">-27.5%</font>) has decided to <a href=\"https://seekingalpha.com/pr/17665574-syros-announces-update-selective-cdk7-inhibitor-portfolio\" target=\"_blank\">terminate development</a> of intravenously administered CDK7 inhibitor SY-1365. A Phase 1 study should launch next quarter.</li><li>Investors appear to be reacting to the abrupt switch and longer timeline since the company was supposed to <a href=\"https://seekingalpha.com/news/3420994-syros-announces-expected-milestones\" target=\"_blank\">release data</a> from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03134638?lead=syros+pharmaceuticals&amp;rank=1\" target=\"_blank\">Phase 1 trial</a> of SY-1365 this quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506555\" data-linked=\"Syros Pharma bails on cancer candidate SY-1365; shares down 28%\" data-tweet=\"$SYRS - Syros Pharma bails on cancer candidate SY-1365; shares down 28% https://seekingalpha.com/news/3506555-syros-pharma-bails-on-cancer-candidate-syminus-1365-shares-down-28?source=tweet\" data-url=\"https://seekingalpha.com/news/3506555-syros-pharma-bails-on-cancer-candidate-syminus-1365-shares-down-28\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506552\" data-ts=\"1571323343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506552-ulta-beauty-perky-on-activist-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ulta Beauty perky on activist chatter</a></h4><ul> <li>Ulta Beauty (<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a> <font color=\"green\">+0.9%</font>) has spiked up a bit in morning action on unconfirmed talk that an activist has taken a stake in the retailer.</li> <li>Pershing Square has been mentioned, although no SEC filings are out yet.</li> <li>Shares of Ulta Beauty are swapping hands at $247.16 at last check vs. the 52-week trading range of $224.42 to $368.83.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506552\" data-linked=\"Ulta Beauty perky on activist chatter\" data-tweet=\"$ULTA - Ulta Beauty perky on activist chatter https://seekingalpha.com/news/3506552-ulta-beauty-perky-on-activist-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3506552-ulta-beauty-perky-on-activist-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506545\" data-ts=\"1571322881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOV\" target=\"_blank\">DOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506545-dover-up-5-after-q3-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dover up 5% after Q3 earnings beat</a></h4><div><ul><li>Dover (<a href='https://seekingalpha.com/symbol/DOV' title='Dover Corporation'>DOV</a> <font color=\"green\">+5.7%</font>) reported Q3 revenue growth of 4.6% Y/Y to $1.86B, and Adj. EPS increase of 18% Y/Y to $1.60.</li><li>Increase in the quarter was driven by organic growth of 5.6% and acquisition growth of 1%.</li><li>Revenue by segments: Engineered Systems $701.79M (+4.5% Y/Y); Fluids $753.05M (+9.1% Y/Y); and Refrigeration &amp; Food Equipment $370.34M (-4.1% Y/Y).</li><li>Q3 Gross margin <font color=\"red\">declined by 10 bps</font> to 36.9%; operating margin <font color=\"red\">declined by 70 bps</font> to 15.5%.</li><li>Adj. EBITDA was $320M (+17% Y/Y): and margin <font color=\"green\">improved by 160 bps</font> to 21.1%.</li><li>Total segment margin <font color=\"green\">expanded by 300 bps</font> to 17.4%.</li><li>Total consolidated backlog was at $1.39B up 3.5% Y/Y.</li><li>Net cash flows provided by operating activities were $350.87M, compared to $243.94M a year ago.</li><li><strong>FY19 Guidance: </strong>Revenue growth expected to be 2%-3%; reaffirming and tightening FY19 adjusted EPS guidance to $5.82 to $5.85 (prior $5.75 to $5.85).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506415-dover-eps-beats-0_09-beats-revenue\" target=\"_blank\">Dover EPS beats by $0.09, beats on revenue</a> (Oct. 17)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3506545\" data-linked=\"Dover up 5% after Q3 earnings beat\" data-tweet=\"$DOV - Dover up 5% after Q3 earnings beat https://seekingalpha.com/news/3506545-dover-up-5-after-q3-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3506545-dover-up-5-after-q3-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506548\" data-ts=\"1571322797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXT\" target=\"_blank\">TXT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506548-textron-posts-q3-earnings-beat-cuts-cash-flow-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Textron posts Q3 earnings beat but cuts cash flow guidance</a></h4><ul><li>Textron (<a href='https://seekingalpha.com/symbol/TXT' title='Textron Inc.'>TXT</a> <font color='red'>-3.5%</font>) tumbles after reporting better than expected <a href=\"https://seekingalpha.com/news/3506410-textron-eps-beats-0_08-misses-revenue\" target=\"_blank\">Q3 earnings</a> and a slight revenue increase from the prior-year period but reducing its full-year cash flow guidance.</li><li>TXT narrows its full-year EPS outlook to $3.70-$3.80 from $3.65-$3.85 previously, but it now sees manufacturing cash flow before pension contributions of $600M-$700M, down from previous guidance of $700M-$800M; expected pension contributions remain at ~$50M.</li><li>Q3 manufacturing cash flow before pension contributions fell 30% Y/Y to $181M from $259M in the prior-year quarter.</li><li>Q3 Textron Aviation revenues rose 6% Y/Y to $1.2B, primarily due to higher jet and aftermarket volume partially offset by lower defense volume, and Bell revenues edged 1% higher to $783M on higher commercial revenues partially offset by lower military volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506548\" data-linked=\"Textron posts Q3 earnings beat but cuts cash flow guidance\" data-tweet=\"$TXT - Textron posts Q3 earnings beat but cuts cash flow guidance https://seekingalpha.com/news/3506548-textron-posts-q3-earnings-beat-cuts-cash-flow-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3506548-textron-posts-q3-earnings-beat-cuts-cash-flow-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506547\" data-ts=\"1571322637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506547-natural-gas-inventory-build-slightly-less-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory build slightly less than consensus</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+104 Bcf</strong> vs. +106 Bcf consensus, +98 Bcf last week.</li><li>Futures <font color=\"green\">+1.52%</font> to $2.338.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Trust II - ProShares Ultra Bloomberg Natural Gas'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='United States 12 Month Natural Gas Fund, LP'>UNL</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506547\" data-linked=\"Natural gas inventory build slightly less than consensus\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory build slightly less than consensus https://seekingalpha.com/news/3506547-natural-gas-inventory-build-slightly-less-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3506547-natural-gas-inventory-build-slightly-less-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506543\" data-ts=\"1571321753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506543-nuance-microsoft-automating-clinical-documentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuance, Microsoft automating clinical documentation</a></h4><ul><li>Nuance (<a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a> <font color='green'>+2.1%</font>) and Microsoft (<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) <a href=\"https://seekingalpha.com/pr/17666140-nuance-microsoft-partner-transform-doctor-patient-experience\" target=\"_blank\">announce</a> joining forces to accelerate the delivery of ambient clinical intelligence &#40;ACI&#41; tech that helps write clinical documentation.</li><li>The partnership will combine Nuance's healthcare-optimized speech recognition products like Dragon Medical with Microsoft's Azure, Azure AI, and Project EmpowerMD Intelligent Scribe Service.</li><li>The companies will work with long-term electronic health record providers to help develop the tech.</li><li>The ACI tech is expected to reach an initial set of physician specialties in early 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506543\" data-linked=\"Nuance, Microsoft automating clinical documentation\" data-tweet=\"$NUAN $MSFT - Nuance, Microsoft automating clinical documentation https://seekingalpha.com/news/3506543-nuance-microsoft-automating-clinical-documentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3506543-nuance-microsoft-automating-clinical-documentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506539\" data-ts=\"1571321353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSX\" target=\"_blank\">CSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506539-baml-sees-gains-for-csx\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML sees more gains for CSX</a></h4><ul> <li>Bank of America Merrill Lynch reiterates a Buy rating on CSX (<a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a> <font color='green'>+3.3%</font>) after taking in the company's Q3 earnings report.</li> <li>The biggest pullout from the report was that improvements in service and efficiency are set to allow CSX to add up to 30% additional growth at low incremental cost and take margins even higher from <a href=\"https://seekingalpha.com/pr/17665094-csx-announces-third-quarter-2019-financial-results\" target=\"_blank\">record levels</a>.</li> <li>BAML's price objective of $80 works out to 18X the 2020 earnings estimate. The PT was reduced from $82 due to the pricing pressure on coal exports, but still stands above the <a href=\"https://seekingalpha.com/symbol/CSX/ratings/sell-side-ratings\" target=\"_blank\">sell-side consensus</a> mark of $76.64.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506539\" data-linked=\"BAML sees more gains for CSX\" data-tweet=\"$CSX - BAML sees more gains for CSX https://seekingalpha.com/news/3506539-baml-sees-gains-for-csx?source=tweet\" data-url=\"https://seekingalpha.com/news/3506539-baml-sees-gains-for-csx\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506536\" data-ts=\"1571321142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MITO\" target=\"_blank\">MITO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506536-stealth-bio-up-2-on-elamipretide-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stealth Bio up 2% on elamipretide data</a></h4><ul><li>Thinly traded micro cap Stealth BioTherapeutics (<a href='https://seekingalpha.com/symbol/MITO' title='Stealth BioTherapeutics Corp'>MITO</a> <font color=\"green\">+2.2%</font>) perks up, albeit on volume of only 5,300 shares, on the heels of <a href=\"https://seekingalpha.com/pr/17665650-stealth-biotherapeutics-presents-data-elamipretide-cardiac-function-barth-syndrome\" target=\"_blank\">new data</a> from the open-label extension portion of its Phase 2/3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03098797?lead=stealth+biotherapeutics&amp;phase=12&amp;rank=1\" target=\"_blank\">TAZPOWER </a>study evaluating Fast Track-tagged elamipretide in patients with a rare inherited disorder called <a href=\"https://ghr.nlm.nih.gov/condition/barth-syndrome\" target=\"_blank\">Barth syndrome</a>, characterized by an enlarged and weakened heart. The results were presented at the American Society of Human Genetics Annual Meeting in Houston, TX.</li><li>Patients receiving elamipretide, an inner mitochondrial membrane-targeting peptide compound that binds to a molecule called <a href=\"https://www.hindawi.com/journals/bmri/2015/891707/\" target=\"_blank\">cardiolipin </a>that plays a key role in mitochondrial function, experienced a 27% increase in average cardiac stroke volume.</li><li>In April, the company <a href=\"https://seekingalpha.com/news/3451357-stealths-elamipretide-shows-positive-effect-barth-syndrome-extension-study\" target=\"_blank\">announced </a>that TAZPOWER failed to achieve the primary endpoint of a statistically significant improvement in the 6-minute walk test at week 12 versus placebo, but data from the extension phase showed a 40% decrease in the ratio of abnormal to normal cardiolipin, suggesting that a longer duration of treatment may produce a greater treatment effect.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506536\" data-linked=\"Stealth Bio up 2% on elamipretide data\" data-tweet=\"$MITO - Stealth Bio up 2% on elamipretide data https://seekingalpha.com/news/3506536-stealth-bio-up-2-on-elamipretide-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3506536-stealth-bio-up-2-on-elamipretide-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506535\" data-ts=\"1571320842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506535-comtech-wins-1_6m-satellite-modem-order\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech wins $1.6M satellite modem order</a></h4><ul>   <li>Comtech Telecommunications (<a href=\"http://seekingalpha.com/symbol/CMTL\" target=\"_blank\">CMTL</a> <font color=\"green\">+1.6%</font>) has won a <a href=\"https://seekingalpha.com/pr/17666020-comtech-telecommunications-corp-receives-1_6-million-satellite-modem-order-european-ministry\" target=\"_blank\">$1.6M order</a> for satellite modems from a European ministry of defense.</li>    <li>The Q1 order came through its Arizona subsidiary Comtech EF Data Corp., part of the Commercial Solutions segment.</li>    <li>The DMD2050E satellite modems will be deployed at the ministry's teleports in Europe and the Caribbean to upgrade an existing network.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506535\" data-linked=\"Comtech wins $1.6M satellite modem order\" data-tweet=\"$CMTL - Comtech wins $1.6M satellite modem order https://seekingalpha.com/news/3506535-comtech-wins-1_6m-satellite-modem-order?source=tweet\" data-url=\"https://seekingalpha.com/news/3506535-comtech-wins-1_6m-satellite-modem-order\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506525\" data-ts=\"1571319624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNGO\" target=\"_blank\">BNGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506525-bionano-genomics-down-23-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bionano Genomics down 23% on equity offering</a></h4><ul><li>Nano cap Bionano Genomics (<a href='https://seekingalpha.com/symbol/BNGO' title='Bionano Genomics, Inc.'>BNGO</a> <font color=\"red\">-23.2%</font>) slumps out of the gate on double normal volume in reaction to its planned <a href=\"https://www.sec.gov/Archives/edgar/data/1411690/000114036119018566/nt10004193x4_s1a.htm\" target=\"_blank\">public offering</a> of ~5.3M common shares and five-year warrants to purchase up to the same number of shares. Pricing has yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506525\" data-linked=\"Bionano Genomics down 23% on equity offering\" data-tweet=\"$BNGO - Bionano Genomics down 23% on equity offering https://seekingalpha.com/news/3506525-bionano-genomics-down-23-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3506525-bionano-genomics-down-23-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506522\" data-ts=\"1571319311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPB\" target=\"_blank\">CPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506522-rbc-sees-campbell-soup-packaged-food-standout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC sees Campbell Soup as packaged food standout</a></h4><ul> <li>RBC Capital picks Campbell Soup (NYSE:<a href='https://seekingalpha.com/symbol/CPB' title='Campbell Soup Company'>CPB</a>) as just one of its two Outperform ratings in new coverage of the packaged food sector.</li> <li>Analyst Nic Mondi notes that Campbell Soup is shifting to a growth story from a margin expansion play and expects outperformance in some key categories over time.</li> <li>RBC's price target of $55 reps 16% upside potential for shares and is above the sell-side average PT of $44.75, although Mondi and team see an even more significant long-term turnaround taking hold.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506522\" data-linked=\"RBC sees Campbell Soup as packaged food standout\" data-tweet=\"$CPB - RBC sees Campbell Soup as packaged food standout https://seekingalpha.com/news/3506522-rbc-sees-campbell-soup-packaged-food-standout?source=tweet\" data-url=\"https://seekingalpha.com/news/3506522-rbc-sees-campbell-soup-packaged-food-standout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506514\" data-ts=\"1571318905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506514-ford-charges-ahead-ev-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford charges ahead with EV plans</a></h4><ul>  <li>Ford (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) announces a new public charging network in North America that includes more than 12K places for drivers to charge, including fast charging, and more than 35K charge plugs total.</li><li>The automaker says the large network addresses a big concern for those switching to all-electric cars.</li><li>Ford's all-electric vehicles, including the Mustang-inspired SUV arriving next year, will come standard with a Ford Mobile Charger that can charge regardless of outlet power (120- and 240-volt outlets). Drivers with longer commutes or who want greater peace of mind, a Ford Connected Charge Station can fully power a vehicle overnight while they sleep with the Ford Connected Charge Station. Also, drivers can charge their battery from 10% to 80% in 45 minutes through an Electrify America DC fast charger.</li><li>Ford is collaborating with Amazon in the U.S. for installation services \u2013 from 240V outlets to the Ford Connected Charge Station.</li><li>Shares of Ford are up <font color=\"green\">+0.66%</font> premarket to  $9.10.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17665488-ford-introduces-north-america-s-largest-electric-vehicle-charging-network-helping-customers\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3506514\" data-linked=\"Ford charges ahead with EV plans\" data-tweet=\"$F - Ford charges ahead with EV plans https://seekingalpha.com/news/3506514-ford-charges-ahead-ev-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3506514-ford-charges-ahead-ev-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>196&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506510\" data-ts=\"1571318625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CANF\" target=\"_blank\">CANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506510-can-fite-up-59-premarket-on-piclidenoson-event\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Can-Fite up 59% premarket on Piclidenoson event</a></h4><ul><li>Thinly traded nano cap Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) is up <font color=\"green\">59% </font>premarket on robust volume in response to the start of a <a href=\"https://seekingalpha.com/pr/17665759-can-fite-gebro-pharma-holding-european-conference-development-and-commercialization-phase-iii\" target=\"_blank\">two-day conference</a> at licensee Gebro Pharma's headquarters in Austria with key opinion leaders in rheumatoid arthritis &#40;RA&#41;. The experts will be conducting a scientific review of Piclidenoson and its mechanism of action in RA.</li><li>Gebro owns distribution rights in Austria, Switzerland and Spain.</li><li>A Phase 3 study in these patients is in process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506510\" data-linked=\"Can-Fite up 59% premarket on Piclidenoson event\" data-tweet=\"$CANF - Can-Fite up 59% premarket on Piclidenoson event https://seekingalpha.com/news/3506510-can-fite-up-59-premarket-on-piclidenoson-event?source=tweet\" data-url=\"https://seekingalpha.com/news/3506510-can-fite-up-59-premarket-on-piclidenoson-event\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506505\" data-ts=\"1571318408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506505-nflx-acb-among-top-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NFLX, ACB among top premarket gainers</a></h4><ul><li>Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) <font color=\"green\">+75%</font> and Gebro Pharma on <a href=\"https://seekingalpha.com/pr/17665759-can-fite-gebro-pharma-holding-european-conference-development-and-commercialization-phase-iii\" target=\"_blank\">development &amp; commercialization</a> of phase III drug candidate Piclidenoson in the treatment of Rheumatoid Arthritis.</li><li>Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"green\">+54%</font> on <a href=\"https://seekingalpha.com/news/3506418-hepion-pharma-80-percent-encouraging-crv431-data\" target=\"_blank\">encouraging CRV431 data</a>.</li><li>Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group Inc.'>CRON</a>) <font color=\"green\">+25%</font> following <a href=\"https://seekingalpha.com/news/3506385-cronos-flies-high-hours-following-block-trades\" target=\"_blank\">block trades</a>.</li><li>Rekor Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/REKR' title='Rekor Systems, Inc.'>REKR</a>) <font color=\"green\">+14%</font> on <a href=\"https://seekingalpha.com/pr/17665666-rekor-selected-united-states-air-force-deploy-vehicle-recognition-solutions-enhanced-base\" target=\"_blank\">being selected</a> by the United States Air Force to deploy its industry leading vehicle recognition system within a western United States base.</li><li>Avita Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/RCEL' title='Avita Medical Limited'>RCEL</a>) <font color=\"green\">+11%</font>.</li><li>Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) <font color=\"green\">+8%</font>.</li><li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3506288-netflix-eps-beats-0_42-revenue-line\" target=\"_blank\">Q3 results</a>.</li><li>Central European Media Enterprises (NASDAQ:<a href='https://seekingalpha.com/symbol/CETV' title='Central European Media Enterprises Ltd.'>CETV</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3506381-central-european-media-beats-revenue\" target=\"_blank\">Q3 results</a>.</li><li>Telefonaktiebolaget LM Ericsson(NASDAQ:<a href='https://seekingalpha.com/symbol/ERIC' title='Telefonaktiebolaget LM Ericsson &#40;publ&#41;'>ERIC</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3506383-telefonaktiebolaget-lm-ericsson-beats-revenue\" target=\"_blank\">Q3 results</a>.</li><li>Ocugen (NASDAQ:<a href='https://seekingalpha.com/symbol/OCGN' title='Ocugen, Inc.'>OCGN</a>) <font color=\"green\">+4%</font>.</li><li>Alcoa (NYSE:<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/news/3506303-alcoa-eps-misses-0_15-misses-revenue\" target=\"_blank\">Q3 results</a>.</li><li>Top Ships (NASDAQ:<a href='https://seekingalpha.com/symbol/TOPS' title='Top Ships Inc.'>TOPS</a>) <font color=\"green\">+5%</font>.</li><li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/pr/17665331-consumer-legalization-one-year-later-aurora-cannabis-reveals-sneak-peek-plans-nextgen\" target=\"_blank\">plans</a> for NextGen cannabis products.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506505\" data-linked=\"NFLX, ACB among top premarket gainers\" data-tweet=\"$CANF $HEPA $CRON - NFLX, ACB among top premarket gainers https://seekingalpha.com/news/3506505-nflx-acb-among-top-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506505-nflx-acb-among-top-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506499\" data-ts=\"1571317847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAKE\" target=\"_blank\">CAKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506499-cheesecake-factoryminus-2-after-raymond-james-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheesecake Factory -2% after Raymond James cut</a></h4><ul> <li>Shares of Cheesecake Factory (NASDAQ:<a href='https://seekingalpha.com/symbol/CAKE' title='The Cheesecake Factory Incorporated'>CAKE</a>) slip in early trading after Raymond James drops the restaurant stock to a Market Perform rating from Outperform.</li> <li>The cut by RJ places the firm in the same position as a <a href=\"https://seekingalpha.com/symbol/CAKE/ratings/sell-side-ratings\" target=\"_blank\">majority</a> of the sell-side CAKE watchers (5 Buy-equivalent ratings, 17 Hold-equivalent ratings, 1 Sell-equivalent rating).</li> <li>CAKE <font color=\"red\">-2.34%</font> premarket to $37.50 vs. the 52-week trading range of $35.83 to $52.91.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506499\" data-linked=\"Cheesecake Factory -2% after Raymond James cut\" data-tweet=\"$CAKE - Cheesecake Factory -2% after Raymond James cut https://seekingalpha.com/news/3506499-cheesecake-factoryminus-2-after-raymond-james-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3506499-cheesecake-factoryminus-2-after-raymond-james-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506498\" data-ts=\"1571317676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506498-ibm-bngo-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM, BNGO among premarket losers</a></h4><ul><li>Bionano Genomics (NASDAQ:<a href='https://seekingalpha.com/symbol/BNGO' title='Bionano Genomics, Inc.'>BNGO</a>) <font color=\"red\">-31%</font>.</li><li>Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"red\">-9%</font> on <a href=\"https://seekingalpha.com/news/3506472-pareteum-minus-3_9-percent-street-low-target\" target=\"_blank\">analyst</a> rating.</li><li>Xenetic Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a>) <font color=\"red\">-6%</font>.</li><li>International Business Machines (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3506302-ibm-eps-beats-0_02-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506498\" data-linked=\"IBM, BNGO among premarket losers\" data-tweet=\"$BNGO $TEUM $XBIO - IBM, BNGO among premarket losers https://seekingalpha.com/news/3506498-ibm-bngo-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506498-ibm-bngo-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506492\" data-ts=\"1571317128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAX\" target=\"_blank\">BAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506492-baxter-in-talks-sanofi-for-seprafilm-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baxter in talks with Sanofi for Seprafilm unit</a></h4><ul><li>Baxter International (NYSE:<a href='https://seekingalpha.com/symbol/BAX' title='Baxter International Inc.'>BAX</a>) is reportedly negotiating with Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) to acquire its <a href=\"https://www.seprafilm.us/\" target=\"_blank\">Seprafilm</a> business for $300M - 400M.</li><li>Seprafilm makes an adhesion barrier used in abdominal or pelvic laparotomy (surgical incision into the abdominal or pelvic cavity) as an adjunct to reduce the risk and severity of postoperative adhesions between the abdominal wall and underlying viscera.</li><li>SNY is up <font color=\"green\">1%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506492\" data-linked=\"Baxter in talks with Sanofi for Seprafilm unit\" data-tweet=\"$BAX $SNY - Baxter in talks with Sanofi for Seprafilm unit https://seekingalpha.com/news/3506492-baxter-in-talks-sanofi-for-seprafilm-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3506492-baxter-in-talks-sanofi-for-seprafilm-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506487\" data-ts=\"1571316289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPC\" target=\"_blank\">GPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506487-genuine-parts-lowered-fy2019-revenue-and-earnings-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genuine Parts lowered FY2019 revenue and earnings outlook</a></h4><ul><li>Genuine Parts (NYSE:<a href='https://seekingalpha.com/symbol/GPC' title='Genuine Parts Company'>GPC</a>) reports comparable growth of 1.2% in <a href=\"https://seekingalpha.com/pr/17665924-genuine-parts-company-reports-sales-earnings-third-quarter-ended-september-30-2019\" target=\"_blank\">Q3</a>.</li><li>Acquisition contributed 6.7% point of growth in sales for the quarter.</li><li>Automotive group net sales up 5.3% to $2.79B.</li><li>Industrial net sales axpanded 9.9% to $1.73B.</li><li>Business Products net sales fell 0.9% to $491.59M.</li><li>Gross margin rate improved 100 bps to 32.4%.</li><li>Operating margin rate down 10 bps to 7.6%.</li><li><b>FY2019 Guidance</b>: Sales: ~+3.5% from prior guidance of +4.5% to +5.5%; Tax rate: ~25%; Diluted EPS: $5.44 to $5.52 from $5.42 to $5.52; Adjusted EPS: $5.60 to $5.68 from prior guidance of $5.65 to $5.75.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506482-genuine-parts-eps-beats-0_03-misses-revenue\" target=\"_blank\">Genuine Parts EPS beats by $0.03, misses on revenue</a> (Oct. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506487\" data-linked=\"Genuine Parts lowered FY2019 revenue and earnings outlook\" data-tweet=\"$GPC - Genuine Parts lowered FY2019 revenue and earnings outlook https://seekingalpha.com/news/3506487-genuine-parts-lowered-fy2019-revenue-and-earnings-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3506487-genuine-parts-lowered-fy2019-revenue-and-earnings-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506484\" data-ts=\"1571316093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOMX\" target=\"_blank\">FOMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506484-fda-accepts-foamix-application-for-rosacea-topical-fmx103-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts Foamix application for rosacea topical FMX103; shares up 1%</a></h4><ul><li>Foamix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/FOMX' title='Foamix Pharmaceuticals Ltd.'>FOMX</a>) is up <font color=\"green\">1%</font> premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/17665746-foamix-announces-fda-acceptance-new-drug-application-fmx103-minocycline-foam-treatment\" target=\"_blank\">announcement </a>that the FDA has accepted for review its marketing application for FMX103 (minocycline topical foam 1.5%) for the treatment of adults with moderate-to-severe papulopustular rosacea.</li><li>The agency's action date is June 2, 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506484\" data-linked=\"FDA accepts Foamix application for rosacea topical FMX103; shares up 1%\" data-tweet=\"$FOMX - FDA accepts Foamix application for rosacea topical FMX103; shares up 1% https://seekingalpha.com/news/3506484-fda-accepts-foamix-application-for-rosacea-topical-fmx103-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3506484-fda-accepts-foamix-application-for-rosacea-topical-fmx103-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506483\" data-ts=\"1571315983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNP\" target=\"_blank\">UNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506483-union-pacific-misses-q3-estimates-freight-volumes-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Union Pacific misses Q3 estimates as freight volumes fall</a></h4><ul><li>Union Pacific (NYSE:<a href='https://seekingalpha.com/symbol/UNP' title='Union Pacific Corporation'>UNP</a>) <font color=\"red\">-3.2%</font> pre-market after <a href=\"https://seekingalpha.com/news/3506463-union-pacific-eps-misses-0_09-misses-revenue\" target=\"_blank\">Q3 earnings</a> and revenues both miss Wall Street expectations, as core pricing gains were offset by lower volumes, decreased fuel surcharge revenue and negative mix.</li><li>UNP says Q3 operating revenue fell 7% Y/Y to $5.5B and business volumes, as  measured by total revenue carloads, dropped 8%.</li><li>Broken down by unit, freight revenues fell 1% in the agricultural products, industrial and premium segments, while the energy unit tumbled 20%.</li><li>UNP says its 59.5% operating ratio in the quarter was an all-time best and improved 2.2 points from the year-ago quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506483\" data-linked=\"Union Pacific misses Q3 estimates as freight volumes fall\" data-tweet=\"$UNP - Union Pacific misses Q3 estimates as freight volumes fall https://seekingalpha.com/news/3506483-union-pacific-misses-q3-estimates-freight-volumes-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/3506483-union-pacific-misses-q3-estimates-freight-volumes-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506481\" data-ts=\"1571315700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506481-gabelli-likes-teva-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gabelli likes Teva in premarket analyst action</a></h4><ul><li>ArQule (NASDAQ:<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a>) initiated with Overweight rating and $16 (78% upside) price target at Cantor Fitzgerald. Shares up <font color=\"green\">4%</font> premarket.</li><li>Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>) initiated with Overweight rating and $8 (60% upside) price target at Stephens. Shares up a fraction premarket.</li><li>IDEAYA Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/IDYA' title='IDEAYA Biosciences, Inc.'>IDYA</a>) initiated with Outperform rating and $17 (166% upside) price target at Oppenheimer.</li><li>NGM Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/NGM' title='NGM Biopharmaceuticals, Inc.'>NGM</a>) initiated with Buy rating at B. Riley FBR.</li><li>Recro Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/REPH' title='Recro Pharma, Inc.'>REPH</a>) initiated with Overweight rating and $14 (19% upside) price target at Stephens.</li><li>TherapeuticsMD (NASDAQ:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD, Inc.'>TXMD</a>) initiated with Buy rating and $7 (90% upside) price target at H.C. Wainwright. Shares up <font color=\"green\">3% </font>premarket.</li><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) upgraded to Buy at Gabelli citing valuation and the potential for a global opioid settlement. Shares up <font color=\"green\">3%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506481\" data-linked=\"Gabelli likes Teva in premarket analyst action\" data-tweet=\"$CDMO $NGM $REPH - Gabelli likes Teva in premarket analyst action https://seekingalpha.com/news/3506481-gabelli-likes-teva-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3506481-gabelli-likes-teva-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506474\" data-ts=\"1571315297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLX\" target=\"_blank\">PLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506474-protalix-up-18-premarket-on-longer-term-prxminus-102-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Protalix up 18% premarket on longer-term PRX-102 data</a></h4><ul><li>Thinly traded nano cap Protalix BioTherapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLX' title='Protalix BioTherapeutics, Inc.'>PLX</a>) is up <font color=\"green\">18%</font> premarket on modest volume in reaction to <a href=\"https://seekingalpha.com/pr/17665675-protalix-biotherapeutics-announces-positive-12-month-interim-data-bridge-phase-iii-open-label\" target=\"_blank\">12-month data</a> on pegunigalsidase alfa (PRX-102) from the first 16 Fabry subjects in the open-label Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03018730?lead=protalix&amp;phase=2&amp;rank=4\" target=\"_blank\">BRIDGE</a> switchover study.</li><li>At month 12, 16 of 22 enrolled patients who were on a stable regimen of agalsidase alfa [Takeda's (NYSE:<a href='https://seekingalpha.com/symbol/TAK' title='Takeda Pharmaceutical Company Limited'>TAK</a>) Replagal] who switched to pegunigalsidase alfa experienced a mean improvement in kidney function with a favorable safety profile.</li><li>The results were consistent with six-month data <a href=\"https://seekingalpha.com/news/3392180-protalix-20-percent-positive-prxminus-102-data-fabry\" target=\"_blank\">announced </a>in about a year ago.</li><li>Development is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506474\" data-linked=\"Protalix up 18% premarket on longer-term PRX-102 data\" data-tweet=\"$PLX $TAK - Protalix up 18% premarket on longer-term PRX-102 data https://seekingalpha.com/news/3506474-protalix-up-18-premarket-on-longer-term-prxminus-102-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3506474-protalix-up-18-premarket-on-longer-term-prxminus-102-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506472\" data-ts=\"1571315008\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506472-pareteumminus-3_9-after-street-low-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum -3.9% after Street-low target</a></h4><ul><li>Craig-Hallum downgrades Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) from Buy to Hold, citing signs of an \"internal civil war\" after recent exec departures that included the COO.</li><li>Analyst George Sutton says the firm can't hide its \"disappointment with some of the moves made over the past several months\" and that the disruption within TEUM's management \"provides questions and few answers.\"</li><li>The firm cuts its TEUM target from $6 to $1.</li><li>TEUM shares are <font color=\"red\">down 3.9%</font> pre-market to $0.99. The company has a Buy average <a href=\"https://seekingalpha.com/symbol/TEUM/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a> with Craig-Hallum as the first to not have a Buy-equivalent rating.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506472\" data-linked=\"Pareteum -3.9% after Street-low target\" data-tweet=\"$TEUM - Pareteum -3.9% after Street-low target https://seekingalpha.com/news/3506472-pareteumminus-3_9-after-street-low-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3506472-pareteumminus-3_9-after-street-low-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506463\" data-ts=\"1571313763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNP\" target=\"_blank\">UNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506463-union-pacific-eps-misses-0_09-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Union Pacific EPS misses by $0.09, misses on revenue</a></h4><ul><li>Union Pacific (NYSE:<a href='https://seekingalpha.com/symbol/UNP' title='Union Pacific Corporation'>UNP</a>): Q3 GAAP EPS of $2.22 <font color=\"red\">misses by $0.09</font>.</li><li>Revenue of $5.52B (-6.9% Y/Y) <font color=\"red\">misses by $130M</font>.</li><li>Shares <font color=\"green\">+1.03%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17665807-union-pacific-reports-third-quarter-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3506463\" data-linked=\"Union Pacific EPS misses by $0.09, misses on revenue\" data-tweet=\"$UNP - Union Pacific EPS misses by $0.09, misses on revenue https://seekingalpha.com/news/3506463-union-pacific-eps-misses-0_09-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3506463-union-pacific-eps-misses-0_09-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506450\" data-ts=\"1571313121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTT\" target=\"_blank\">QTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506450-qutoutiao-completes-100m-financing-sharesplus-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qutoutiao completes $100M financing; shares +2%</a></h4><ul><li>Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao Inc.'>QTT</a>) <a href=\"https://seekingalpha.com/pr/17665124-qutoutiao-announces-completion-100-million-financing-midu\" target=\"_blank\">announces</a> that its subsidiary completed the Series B financing led by CMC Capital.</li><li>The subsidiary contains the operations of <em>Midu Novels</em> and <em>Midu Novels Lite. </em></li><li>QTT shares are <font color=\"green\">up 2.1%</font> pre-market to $3.44.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506450\" data-linked=\"Qutoutiao completes $100M financing; shares +2%\" data-tweet=\"$QTT - Qutoutiao completes $100M financing; shares +2% https://seekingalpha.com/news/3506450-qutoutiao-completes-100m-financing-sharesplus-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3506450-qutoutiao-completes-100m-financing-sharesplus-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506448\" data-ts=\"1571312632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506448-cirrus-logic-loses-bear-sharesplus-1_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cirrus Logic loses a bear; shares +1.7%</a></h4><ul><li>Barclays upgrades Cirrus Logic (NASDAQ:<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a>) from Underweight to Equal-Weight, citing the potential benefits from the 5G iPhone model expected to release next year.</li><li>Analyst Blayne Curtis: \"We no longer see a catalyst to the downside with another beat/raise and a new socket next year.\"</li><li>Barclays raises its CRUS price target from the Street-low $40 to $55.</li><li>CRUS shares are <font color=\"green\">up 1.7%</font> pre-market to $55.50. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/CRUS/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506448\" data-linked=\"Cirrus Logic loses a bear; shares +1.7%\" data-tweet=\"$CRUS - Cirrus Logic loses a bear; shares +1.7% https://seekingalpha.com/news/3506448-cirrus-logic-loses-bear-sharesplus-1_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3506448-cirrus-logic-loses-bear-sharesplus-1_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506446\" data-ts=\"1571312344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506446-fda-accepts-application-for-astrazeneca-daiichi-adc-for-breast-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts application for AstraZeneca/Daiichi ADC for breast cancer</a></h4><ul><li>Daiichi Sankyo (<a href='https://seekingalpha.com/symbol/DSNKY' title='Daiichi Sankyo Company, Limited'>OTCPK:DSNKY</a>) and commercialization partner AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a>) <a href=\"https://seekingalpha.com/pr/17665585-fam-trastuzumab-deruxtecan-granted-fda-priority-review-treatment-patients-her2-positive\" target=\"_blank\">announce </a>that the FDA has accepted for review the marketing application for antibody-drug conjugate &#40;ADC&#41; [fam-] trastuzumab deruxtecan (DS-8201) for HER2-positive metastatic breast cancer. Under Priority Review status, the agency's action date is in Q2 2020.</li><li>The companies are jointly developing and commercializing the product globally (expect Japan where Daiichi has exclusive rights) under a March 2019 agreement.</li><li>AZN is up <font color=\"green\">1%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506446\" data-linked=\"FDA accepts application for AstraZeneca/Daiichi ADC for breast cancer\" data-tweet=\"$AZN $DSNKY $DSNKY - FDA accepts application for AstraZeneca/Daiichi ADC for breast cancer https://seekingalpha.com/news/3506446-fda-accepts-application-for-astrazeneca-daiichi-adc-for-breast-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3506446-fda-accepts-application-for-astrazeneca-daiichi-adc-for-breast-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506445\" data-ts=\"1571312308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSO\" target=\"_blank\">WSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506445-watsco-reports-mixed-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Watsco reports mixed Q3 results</a></h4><ul><li>Watsco (NYSE:<a href='https://seekingalpha.com/symbol/WSO' title='Watsco, Inc.'>WSO</a>) reports 3% growth on a same-store basis in <a href=\"https://seekingalpha.com/pr/17665665-watsco-reports-record-sales-income-earnings-per-share-third-quarter\" target=\"_blank\">Q3</a>.</li><li>The company saw 4% growth in HVAC equipment (including 6% growth in residential products) and 2% increase in other HVAC products.</li><li>Commercial refrigeration products sales up 1%.</li><li>Gross margin rate down 60 bps to 24%.</li><li>Operating margin rate declined 40 bps to 9%.</li><li>The company\u2019s e-commerce revenues are expected to approach $1.5B for FY2019.</li><li>Albert H. Nahmad, Watsco\u2019s Chairman and CEO stated: \u201cWatsco produced strong cash flow and record performance that reflects sales growth across the Company\u2019s markets, solid revenue and profit contributions from recent acquisitions and improved operating efficiencies. We are optimistic that 2019 will be a record year for our company.\u201d </li><li>Previously: <a href=\"https://seekingalpha.com/news/3506439-watsco-eps-misses-0_05-beats-revenue\" target=\"_blank\">Watsco EPS misses by $0.05, beats on revenue</a> (Oct. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506445\" data-linked=\"Watsco reports mixed Q3 results\" data-tweet=\"$WSO - Watsco reports mixed Q3 results https://seekingalpha.com/news/3506445-watsco-reports-mixed-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3506445-watsco-reports-mixed-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506442\" data-ts=\"1571312013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTLS\" target=\"_blank\">GTLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506442-chart-cuts-full-year-earnings-revenue-guidance-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chart cuts full-year earnings, revenue guidance below consensus</a></h4><ul><li>Chart Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/GTLS' title='Chart Industries, Inc.'>GTLS</a>) <font color=\"red\">-3.5%</font> pre-market after edging <a href=\"https://seekingalpha.com/news/3506404-chart-eps-beats-0_01-misses-revenue\" target=\"_blank\">Q3 earnings</a> estimates and improving revenues by 31% Y/Y to $358M but slashing its full-year earnings and revenue outlook.</li><li>For FY 2019, GTLS lowers EPS guidance to $2.70-$2.90 from $2.85-$3.20 previously and below $2.97 analyst consensus estimate, and now sees revenues of $1.33B-$1.35B vs. $1.41B-$1.46B previously and $1.42 consensus.</li><li>GTLS says it expects Q4 to be \"very strong\" on order timing, including three potential orders each more than $20M, plus increasing year-end order activity across the segments with the exception of upstream and natural gas processing.</li><li>For FY 2020, GTLS says it base outlook sees EPS of $4.75-$5.25, in line with $5.08 consensus, and revenues of $1.61B-$1.68B, below $1.77B consensus.</li><li>The company says orders of $286M contributed  to total record backlog of $755M, an organic increase over year-end 2018 even when excluding the Calcasieu Pass $135M order.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506442\" data-linked=\"Chart cuts full-year earnings, revenue guidance below consensus\" data-tweet=\"$GTLS - Chart cuts full-year earnings, revenue guidance below consensus https://seekingalpha.com/news/3506442-chart-cuts-full-year-earnings-revenue-guidance-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3506442-chart-cuts-full-year-earnings-revenue-guidance-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506441\" data-ts=\"1571312012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MS\" target=\"_blank\">MS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506441-morgan-stanley-eps-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley EPS beats by $0.09, beats on revenue</a></h4><ul><li>Morgan Stanley (NYSE:<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a>): Q3 Non-GAAP EPS of $1.21 <font color=\"green\">beats by $0.09</font>; GAAP EPS of $1.27 <font color=\"green\">beats by $0.16</font>.</li><li>Revenue of $10.03B (+1.6% Y/Y) <font color=\"green\">beats by $400M</font>.</li><li>Shares <font color=\"green\">+1.4%</font> PM.</li><li><a href=\"https://seekingalpha.com/filing/4666092\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3506441\" data-linked=\"Morgan Stanley EPS beats by $0.09, beats on revenue\" data-tweet=\"$MS - Morgan Stanley EPS beats by $0.09, beats on revenue https://seekingalpha.com/news/3506441-morgan-stanley-eps-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3506441-morgan-stanley-eps-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}